| THE UNIVERSITY OF TOKYO Patent applications |
| Patent application number | Title | Published |
|---|
| 20120136140 | ANTI-CADHERIN ANTIBODY - It is an object of the present invention to provide an anti-cadherin antibody having high antibody-dependent cellular cytotoxicity. The present invention provides an anti-cadherin antibody, which recognizes any one of an upstream region of EC1, a cadherin domain 4 (EC4) and a cadherin domain 5 (EC5), wherein an antibody-dependent cellular cytotoxicity at an antibody concentration of 1 μg/mL is 30% or more. | 05-31-2012 |
| 20120135955 | External Preparation Containing NSAIDs And Method For Producing The External Preparation - Disclosed is an external preparation containing nonsteroidal anti-inflammatory drugs (NSAIDs), which is suppressed in cytotoxicity induced by the NSAIDs. Also disclosed is a method for producing the external preparation. The present invention is based on the finding that skin disorders induced by nonsteroidal anti-inflammatory drugs (NSAIDs) can be suppressed when the NSAIDs form intermolecular compounds together with trehalose, which is an example of disaccharides. A disaccharide other than trehalose may be used therefor. | 05-31-2012 |
| 20120135861 | PHOTOCATALYTIC MATERIALS AND PROCESS FOR PRODUCING THE SAME - The present invention relates to a photocatalytic material having a visible light activity which includes a tungsten-doped titanium oxide or a tungsten/gallium-codoped titanium oxide, and a divalent copper salt and/or a trivalent iron salt supported on a surface of the doped or codoped titanium oxide, and a process for producing the photocatalytic material. | 05-31-2012 |
| 20120135439 | METHOD FOR PRODUCTION OF ACCUMULATED PRODUCT OF NANO-SUBSTANCE, ACCUMULATED PRODUCT OF NANO-SUBSTANCE, DEVICE COMPRISING THE ACCUMULATED PRODUCT, AND METHOD FOR ANALYSIS OF STRUCTURE OF NANO-SUBSTANCE - A method for producing an accumulated product of a nano-substance that enables the accumulated product of the nano-substance to be produced at low cost, by a simple process that requires few conditions to be controlled and requires minimal energy, and with good reproducibility. Specifically, a method for producing an accumulated product of a nano-substance, the method including crystallizing a protein in a state where the protein and the nano-substance co-exist within a solvent, thereby accumulating the nano-substance within pores of the protein crystals to obtain the accumulated product of the nano-substance. | 05-31-2012 |
| 20120135433 | PROGNOSIS DIAGNOSIS METHOD AND PROGNOSIS DIAGNOSIS KIT FOR SEPSIS OR MULTIPLE ORGAN FAILURE - Disclosed are: a prognosis diagnosis method which can diagnose the prognosis of a patient suffering from sepsis or sepsis-related multiple organ failure in a simple manner and with high accuracy and a prognosis diagnosis kit for use in the prognosis diagnosis method. The prognosis diagnosis method comprises: a first detection step of detecting a liver fatty acid-binding protein contained in urine collected from a subject with a specific antibody; a second detection step of treating the urine with a Redox reagent such as hemin and detecting a liver fatty acid-binding protein contained in the treated urine with the specific antibody; and a comparison step of comparing a detection value obtained in the first step with a detection value obtained in the second step. It is determined that the larger the detection value obtained in the second step compared to that in the first step, the worse the prognosis. | 05-31-2012 |
| 20120130064 | METHOD FOR THE HYDROPHILIC PROCESSING OF CELLULOSE FIBRE AND PRODUCTION METHOD FOR HYDROPHILIC CELLULOSE FIBRE - This invention provides a method for hydrophilic treatment of cellulose fibers that can prevent coloring or decrease in fiber strength. The hydrophilic treatment method comprises a first oxidation step of oxidizing cellulose fibers in a first reaction solution containing an N-oxyl compound and a re-oxidizing agent for the N-oxyl compound; and a second oxidation step of oxidizing oxycellulose fibers obtained in the first oxidation step in a second reaction solution containing an oxidizing agent for oxidizing aldehyde groups. | 05-24-2012 |
| 20120128694 | THERAPEUTIC AGENTS FOR ALZHEIMER'S DISEASE AND CANCER - To provide a therapeutic drug for Alzheimer's disease and/or a cancer. | 05-24-2012 |
| 20120128678 | DIAGNOSIS AND TREATMENT OF CANCER USING ANTI-TMPRSS11E ANTIBODY - [Problem to be Solved] | 05-24-2012 |
| 20120123542 | Artificial Bone Constituent Unit And Artificial Bone Constituent System - Provided are an artificial bone constructing unit which is capable of being built into a free shape according to build-up design, and effectively guiding bone replacement, and an artificial bone system. Specifically disclosed are an artificial bone constructing unit and an artificial bone constructing system, wherein in principal, the artificial bone constructing unit which constructs an artificial bone is so made into a block shape that when blocks are assembled, continuous holes through a plurality of blocks are formed. | 05-17-2012 |
| 20120122949 | ULTRA-HIGH STRENGTH INJECTABLE HYDROGEL AND PROCESS FOR PRODUCING THE SAME | 05-17-2012 |
| 20120116036 | PRODUCTION METHOD OF COPOLYMER OF ALLYL MONOMER CONTAINING POLAR GROUP - The present invention relates to a method for producing a high-molecular-weight copolymer of polar group-containing allyl monomers including monomer units represented by formulae (3) and (4) (in the formulae, R | 05-10-2012 |
| 20120100536 | ASSOCIATION OF HTRA1 MUTATIONS AND FAMILIAL ISCHEMIC CEREBRAL SMALL-VESSEL DISEASE - The present invention provides a method of diagnosing a cerebrovascular disease in a human comprising the steps of: (a) measuring a mutation of HTRA1 gene in a test sample from said human; and (b) determining if the mutation of HTRA1 gene in said test sample correlates with a cerebrovascular disease in said human. | 04-26-2012 |
| 20120100064 | PROCESS FOR PRODUCTION OF MAGNETIC THIN FILM, MAGNETIC THIN FILM, AND MAGNETIC MATERIAL - The present invention provides a process for production of a magnetic thin film which has insulation properties, serves as a permanent magnet, and has improved residual magnetization in comparison with prior arts, the magnetic thin film, and a magnetic material. When a magnetic thin film | 04-26-2012 |
| 20120097169 | Resin Product For Medical Use And Respiration-Assisting Tube - Disclosed is a respiration-assisting tube whereby tissue damages in vivo can be prevented and, as a result, inflammatory reactions and infections can be avoided. The respiration-assisting tube is developed based on the finding that adhesion of cells to a respiration-assisting tube can be inhibited by coating the respiration-assisting tube with a polymer containing 2-methacryloyloxyethyl phosphorylcholine (MPC). Also, the respiration-assisting tube is developed based on the finding that, by coating a respiration-assisting tube with a polymer containing MPC, mucosa peeling and tissue damages, which occur after using the respiration-assisting tube, can be prevented and, as a result, inflammatory reactions can be avoided. | 04-26-2012 |
| 20120092003 | MAGNETIC-ELECTRIC ENERGY CONVERSION DEVICE, POWER SUPPLY DEVICE, AND MAGNETIC SENSOR - A magnetic-electric energy conversion device includes: a matrix ( | 04-19-2012 |
| 20120089877 | CONTROL DEVICE AND DATA STORAGE DEVICE - When write request signal is input from a host device | 04-12-2012 |
| 20120076836 | POLYION COMPLEX OF DOUBLE-STRANDED RIBONUCLEIC ACID - Provided are a delivery system that is useful in delivering a double-stranded ribonucleic acid that functions in gene silencing in glomeruli, particularly in mesangial cells and the like, to the tissue or cells, and the like. A polyion complex in the form of a non-polymeric micelle consisting of a double-stranded ribonucleic acid and a block copolymer represented by the formula (I) or (II) below, which are electrostatically bound together, wherein the polyion complex has an average particle diameter of less than 100 nm as measured by a dynamic light scattering measuring method: | 03-29-2012 |
| 20120072801 | DATA PROCESSING APPARATUS, CONTROL DEVICE AND DATA STORAGE DEVICE - When write data D is high rewritten data, a PC | 03-22-2012 |
| 20120070873 | METHOD OF FIXING RAIL MOLECULE AND NANO TRANSPORT DEVICE - An object is to move a rail molecule by means of a biomolecular motor deposited on a base and inactivate the biomolecular motor through irradiation with light having a predetermined wavelength, to thereby readily and reliably fix the rail molecule at a predetermined position, while orienting the rail molecule in a predetermined direction without employment of any reagent. A method for fixing a rail molecule which has polarity and on which a biomolecular motor moves in a direction corresponding to the polarity includes depositing a biomolecular motor on a base; moving a rail molecule by means of the biomolecular motor; and inactivating the biomolecular motor by irradiating the biomolecular motor with light having a predetermined wavelength when the rail molecule reaches a predetermined position, to thereby fix the rail molecule so that it is oriented in a predetermined direction. | 03-22-2012 |
| 20120065384 | FLUORESCENT MRI PROBE - A fluorescent gadolinium complex compound comprising a residue of gadolinium.1,4,7,10-tetraazacyclododecane-N,N′,N″,N′″-tetraacetic acid or a residue of gadolinium.diethylenetriaminepentaacetic acid bound covalently with a group represented by the following general formula (I) (R | 03-15-2012 |
| 20120064346 | FINE PARTICLES OF CRYSTALLINE POLYOL, AND METHOD OF PREPARING SAME - Fine particles of crystalline polyol are provided having a cationic polymer fixed on the crystal surfaces. These fine particles can stably carry an anionically charged compound on their surfaces. | 03-15-2012 |
| 20120059147 | METHOD FOR SITE-SELECTIVELY CLEAVING TARGET NUCLEIC ACID - There is provided a method for cleaving a target nucleic acid at a desired site using a metal ion or a metal ion complex as a catalyst for cleaving a nucleic acid (DNA, etc.), which has high site-selectivity, high reaction efficiency and low side-reactivity (non-specific reactivity), and is economical and convenient. The method for cleaving a target nucleic acid of the present invention comprises allowing a target nucleic acid to come into contact with a specific complex compound and a metal ion or a metal complex, or allowing a target nucleic acid to come into contact with a specific complex compound, to which a metal ion or a metal complex binds. | 03-08-2012 |
| 20120059061 | NOVEL ANTI-INFLAMMATORY COMPOUNDS - An object of the present invention is to provide a compound having a novel structure for overcoming the defects of conventional steroid agents and NSAIDs. It is found that the particular dihydroxy bodies of eicosapentaenoic acid and docosahexaenoic acid, which have not conventionally been known (11,18-dihydroxy eicosapentaenoic acid (11,18-diHEPE), 17,18-dihydroxy eicosapentaenoic acid (17,18-diHEPE) etc.), have activity of inhibiting neutrophil, thereby solving the object. The present invention unexpectedly remarkably inhibits infiltration into a tissue of, and activation of neutrophil found out at acute inflammation. The compound of the present invention is a compound which has not conventionally been known. Therefore, utility as a new therapeutic is provided. | 03-08-2012 |
| 20120058627 | COMPOUND SEMICONDUCTOR DEPOSITION METHOD AND APPARATUS - Provided is a compound semiconductor deposition method of adjusting the luminous wavelength of a compound semiconductor of a ternary or higher system in a nanometer order in depositing the compound semiconductor on a substrate. In the compound semiconductor deposition method of depositing a compound semiconductor of a ternary or higher system on a substrate, propagation light of a smaller energy than a desired ideal excitation energy for the compound semiconductor is irradiated onto the substrate | 03-08-2012 |
| 20120046453 | PROTEIN CHARGE REGULATOR AND PROTEIN-ENCAPSULATING POLYMER MICELLE COMPLEX - The present invention provides a protein delivery means (e.g., a polyion complex) which allows efficient introduction into cells (particularly into the cytoplasm), is highly stable in serum, and is also widely applicable. The polyion complex of the present invention comprises a cationic polymer having a polycation moiety and a charge-conversional protein whose overall charge is converted from basic or neutral to acidic by a specific charge regulator. | 02-23-2012 |
| 20120045096 | MONITORING CAMERA TERMINAL - A monitoring camera terminal has an imaging portion for imaging a monitoring target area allocated to an own-terminal, an object extraction portion for processing a frame image imaged by the imaging portion to extract an imaged object, an ID addition portion for adding an ID to the object extracted by the object extraction portion, an object map creation portion for creating, for each object extracted by the object extraction portion, an object map associating the ID added to the object with a coordinate position in the frame image, and a tracing portion for tracing an object in the monitoring target area allocated to the own-terminal using the object maps created by the object map creation portion. | 02-23-2012 |
| 20120042200 | CONTROL DEVICE AND DATA STORAGE DEVICE - The SSD performs to encode input data from the host device into BCH code having data length Sdr and code length Scr sequentially (step S | 02-16-2012 |
| 20120039879 | STREPTAVIDIN HAVING LOW IMMUNOGENICITY AND USE THEREOF - It is an object of the present invention to provide a mutant streptavidin wherein the immunogenicity (antigenicity) in mammals of a streptavidin is reduced. The present invention provides a mutant streptavidin, which comprises an amino acid sequence in which (a) the arginine residue at position 72 is substituted with another amino acid residue, and (b) any one or more of the tyrosine residue at position 10, the tyrosine residue at position 71, the glutamic acid residue at position 89, the arginine residue at position 91, and the glutamic acid residue at position 104 are substituted with other amino acid residues, with respect to the amino acid sequence of a core streptavidin as shown in SEQ ID NO: 2, and which has decreased immunogenicity as compared with that of a wild-type streptavidin. | 02-16-2012 |
| 20120039808 | Brain Tumor Stem Cell Differentiation Promoter, and Therapeutic Agent for Brain Tumor - A promoter for differentiation of brain tumor initiating cells is provided. | 02-16-2012 |
| 20120029241 | METHOD FOR PRODUCING CARBONYL COMPOUND, CATALYST, AND METHOD FOR PRODUCING CATALYST - The method for producing a carbonyl compound according to the invention comprises a step of obtaining a carbonyl compound by oxidation of a secondary alcohol in the presence of a catalyst, wherein the catalyst comprises a carrier obtained by the use of a styrene-based polymer with side chains containing crosslinkable functional groups, wherein the crosslinkable functional groups in the carrier are crosslinked, gold-platinum nanosize clusters supported on the carrier and carbon black supported on the carrier. The production method allows production of a carbonyl compound by oxidation of a secondary alcohol, with high selectivity and a high conversion rate. | 02-02-2012 |
| 20120027030 | NETWORK TERMINAL, NETWORK SYSTEM, TIME SYNCHRONIZATION METHOD, AND TIME SYNCHRONIZATION PROGRAM - A network terminal has communication section that communicates with other network terminals connected via a network, time-series data creation section that, at timing set beforehand, creates time information including a correspondence between an identification number of the own network terminal and a current time measured by a timer of the own network terminal and creates time-series data registering the time information, and additional registration section that, when the communication section receives the time-series data transmitted from another network terminal, creates time information including a correspondence between the identification number of the own network terminal and a current time measured by the timer of the own network terminal and additionally registers the time information to the time-series data received this time. | 02-02-2012 |
| 20120014870 | Diagnosis and Treatment of Cancer Using Anti-LGR7 Antibody - With dedicated research, the present inventors discovered that not only the LGR7 gene but also the LGR7 protein are highly expressed in clear cell adenocarcinoma cells of ovarian cancer. Furthermore, the present inventors found that anti-LGR7 antibodies have antibody-dependent cell-mediated cytotoxicity (ADCC) activity and complement-dependent cytotoxicity (CDC) activity against LGR7-expressing cells. From the above findings, the present inventors discovered that the anti-LGR7 antibodies are useful for diagnosis, prevention, and treatment of primary and metastatic ovarian clear cell adenocarcinoma. | 01-19-2012 |
| 20120004117 | DIAGNOSIS AND TREATMENT OF CANCER USING ANTI-TM4SF20 ANTIBODY - The present invention relates to an antibody binding to a TM4SF20 protein and the diagnosis and treatment of cancer using the antibody. Specifically, the present invention provides an anti-TM4SF20 antibody and a pharmaceutical composition (e.g., an anticancer agent and a diagnostic drug for cancer) comprising the antibody as an active ingredient. | 01-05-2012 |
| 20120003742 | RECOMBINANT VIRUS, ESCHERICHIA COLI RETAINING THE SAME AND A PROCESS FOR PRODUCTION THEREOF - To provide a method for producing a recombinant virus retaining the characteristics of the genome of a target virus. | 01-05-2012 |
| 20120002923 | SIGNAL TRANSMISSION DEVICE AND MANUFACTURING METHOD THEREFOR - There are provided a signal transmission device capable of improving a production efficiency and reducing a production cost, and a manufacturing method thereof. A spacer | 01-05-2012 |
| 20120000392 | SUSPENSION OF CELLULOSE FIBERS AND METHOD FOR PRODUCING THE SAME - A suspension of cellulose fibers, containing a cellulose fiber, wherein the cellulose fiber contains a cellulose fiber with an average fiber diameter of not more than 200 nm, a content of carboxyl groups in cellulose composing the cellulose fibers is 0.1 to 2 mmol/g, and a metal selected from a polyvalent metal and a monovalent metal (with the proviso that single sodium is excluded) is contained in the cellulose fiber to form a counter ion for the carboxyl group. | 01-05-2012 |
| 20110321204 | NEAR-FIELD OPTICAL MICROSCOPE, NEAR-FIELD OPTICAL PROBE, AND SAMPLE OBSERVATION METHOD - Provided is a scanning near-field optical microscope capable of obtaining in a highly sensitive manner, optical information having a spatial frequency higher than a spatial frequency corresponding to a wavelength of irradiation light. A scanning near-field optical microscope | 12-29-2011 |
| 20110311763 | METHOD FOR PRODUCING TWO-DIMENSIONALLY PATTERNED CARBON NANOTUBE AND TWO-DIMENSIONALLY PATTERNED CARBON NANOTUBE - Disclosed are a method for producing a carbon nanotube (CNT) whereby, in the local synthesis of CNTs, a high resolution, a low cost, easiness in production and mass production capability can be established at the same time; and a two-dimensionally patterned CNT obtained thereby. Specifically disclosed are a method for producing a two-dimensionally patterned CNT which comprises: A) a step for preparing a substrate; B) a step for forming a first two-dimensional pattern, which consists of hydrophobic surface and hydrophilic surface, on the substrate by means of 1) masking and electromagnetic wave irradiation, or 2) electron beam irradiation; C) a step for applying a catalyst-containing solution to the substrate having the first two-dimensional pattern and forming a second two-dimensional pattern depending on the presence or absence of the catalyst; and D) a step for forming by ACCVD a two-dimensional pattern of the CNT on the thus obtained substrate; a substrate; and a structure comprising a two-dimensionally patterned CNT on the aforesaid substrate. | 12-22-2011 |
| 20110306110 | METHOD FOR THREE-DIMENSIONAL HIERARCHICAL CELL CO-CULTURE - A method for preparing a biomaterial comprising a gel layer which forms a core region, and cells (cover cells) which cover around the gel layer, said method comprising the steps of: | 12-15-2011 |
| 20110301116 | NSAIDS-INDUCED GASTROINTESTINAL MUCOSAL DISORDER ALLEVIATOR AND MANUFACTURING METHOD THEREOF - [Problems] The object of the present invention is to provide a Medical Drugs which reduce damage of gastrointestinal mucosal induced by NSAIDs. | 12-08-2011 |
| 20110298534 | INTEGRATED CIRCUIT DEVICE - The channel number detecting circuit | 12-08-2011 |
| 20110292039 | VISUALIZATION PROCESSING METHOD AND APPARATUS - This method includes: generating data of a mask surface with respect to visualization data arranged in a virtual three-dimensional space, for calculation values at respective calculation points; identifying, from a first data storage storing, as time-series data, positions of the calculation points and calculation values at the calculation points, a first point whose position is closest to a predetermined point on the mask surface; reading out, from the first data storage, a position of the identified first point in each time; arranging the mask surface in each time based on a direction of a user's sight line and the read position in each time so as to make the mask surface perpendicular to the direction of the user's sight line and have the predetermined point on the mask surface arranged at the read position; and drawing polygon data of the visualization data and the mask surface in time series. | 12-01-2011 |
| 20110289385 | DATA INPUT / OUTPUT CONTROL DEVICE AND SEMICONDUCTOR MEMORY DEVICE SYSTEM - When detected number of errors data Nerror exceeds the upper limit number of errors Nmax, an error correction circuit of a memory controller stores twice as long data length as stored data length for execution Sdata as the data length for execution Sdata in a correction information memory unit, and code length Scref longer than the data length for execution Sdata and detectable more errors than the upper limit number of errors as the code length for execution Scode in the correction information memory unit | 11-24-2011 |
| 20110288834 | FLUID STRUCTURE INTERACTION SIMULATION METHOD AND APPARATUS, AND COMPUTER-READABLE STORAGE MEDIUM - A fluid structure interaction simulation method includes a graph information forming process to form graph information of nodes obtained by discretising a computing region for each of a fluid and a structure that are represented by meshes, and a main time development loop process to simulate a physical phenomenon. The loop process includes arranging IMEs (Interaction Mediating Elements) that move with a displacement of the structure, on a boundary of the structure, defining, within the IME, correcting functions of a pressure and a velocity of the fluid that interact with the pressure and the velocity of the fluid and the displacement of the structure, and executing a simulation based on the correcting functions, in a state in which the meshes of the fluid are mismatched to the meshes of the structure. | 11-24-2011 |
| 20110288278 | DIAGNOSTIC AGENT AND THERAPEUTIC AGENT FOR PANCREATIC CANCER - The present invention provides a novel diagnostic or therapeutic method for pancreatic cancer employing a blood marker. The present invention provides a diagnostic or therapeutic drug for pancreatic cancer containing an anti-AMIGO2 antibody. | 11-24-2011 |
| 20110287552 | REAGENT FOR MEASURING ACTIVE NITROGEN - A compound represented by the general formula (I) [R | 11-24-2011 |
| 20110283374 | METHOD FOR PRODUCING HETEROGENOUS EMBRYONIC CHIMERIC ANIMAL USING A STEM CELL - A heterologous chimeric animal can be produced by a method comprising the steps of: (A) injecting a stem cell into a blastocyst cavity in a blastocyst stage of an animal heterologous to that of the stem cell, or mixing the stem cell with a divided fertilized egg of the animal heterologous to that of the stem cell; and (B) growing a cell mass including the stem cell prepared in the step (A) into a chimeric animal between a species of the stem cell and a species of the heterologous animal. | 11-17-2011 |
| 20110275106 | DEVICE FOR MEASURING ACTIVITY OF CULTURED CELLS, MICROCHAMBER AND METHOD OF MEASURING ACTIVITY OF CULTURED CELLS - A device for measuring activity of cultured cells includes a position detecting unit specifying a position of a cell to be measured, a microchamber controlling unit disposing in the culture container a microchamber which surrounds the cell and forms a measurement space, the measurement space being minute with respect to a volume of the culture container, and a measuring unit measuring environmental factors contained in the measurement space. | 11-10-2011 |
| 20110263414 | Apatite and method for producing the same, and apatite base material - The present invention relates to apatite that includes metal atoms having a photocatalytic function and other metal atoms, and the metal atoms having a photocatalytic function include metal atoms that absorb energy corresponding to light energy of visible light. By applying the apatite as a base material of various products to be arranged indoors, the photocatalytic function can be exhibited indoors as well. | 10-27-2011 |
| 20110260781 | INTEGRATED CIRCUIT DEVICE - The interposer is disposed on an upper surface of the stacked structure formed by stacking a plurality of a DRAM chip and a plurality of a flash memory chip. Thus down-size of an entire device is accomplished. A boost converter having an inductor is used as a voltage boost circuit. Thus down-size of the entire device is accomplished in comparison to a voltage boost circuit using a charge pump connected in parallel with a plurality of a capacitance. | 10-27-2011 |
| 20110258715 | ORGAN REGENERATION METHOD UTILIZING iPS CELL AND BLASTOCYST COMPLEMENTATION - It is revealed that an organ such as pancreas can be regenerated by utilizing a fact that the deficiency of an organ is complemented by injecting an induced pluripotent stem cell (iPS cell) into a developed blastocyst in a blastocyst complementation method. Thus, the present invention has solved the above-described object. This provides a method for producing a target organ, using an iPS cell, in a living body of a non-human mammal having an abnormality associated with a lack of development of the target organ in a development stage, the target organ produced being derived from a different individual mammal that is an individual different from the non-human mammal. | 10-20-2011 |
| 20110257744 | Method for Producing Artificial Bone and Artificial Bone Produced by the Method - A method for producing an artificial bone capable of accurate molding at a joined part with appropriate strength, in which electromagnetic waves or electron beams are irradiated to a layer of at least type of powder selected from metal biomaterials, ceramics for the artificial bone and plastic resins for the artificial bone based on image data corresponding to a shape of the artificial bone, thereby effecting sintering or melting, and the thus sintered layer or melted and solidified layer is laminated, such that a surface finish step is adopted that inner faces and/or outer faces of both ends and their vicinities configuring the joined part to a human bone part are polished by a rotating tool based on the image data and also irradiation of electromagnetic waves or electron beams at both ends and their vicinities constituting the joined part is set greater than that at other regions, | 10-20-2011 |
| 20110256561 | LIVER DISEASE MARKER, METHOD AND APPARATUS FOR MEASURING THE SAME, AND METHOD FOR ASSAYING PHARMACEUTICAL PREPARATION - A normal person (i.e. a control) and liver diseases such as drug induced liver injury, an asymptomatic hepatitis B carrier, an asymptomatic hepatitis C carrier, chronic hepatitis B, chronic hepatitis C, liver cancer, a nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), and simple steatosis (SS) are identified by measuring the concentrations of γ-Glu-X (X represents an amino acid or an amine) peptides or the levels of AST or ALT in blood and carrying out, for example, a multiple logistic regression based on the measured value. | 10-20-2011 |
| 20110251404 | REAGENT FOR MEASUREMENT OF ACTIVE OXYGEN - A compound represented by the formula (I) (R | 10-13-2011 |
| 20110245481 | METHOD FOR INHIBITING FUNCTION OF micro-RNA - A miRNA-inhibiting RNA complex has a double-stranded structure, in which at least one RNA strand that includes a miRNA-binding sequence is linked to the two strands at at least one end of the double-stranded structure. The complex can efficiently inhibit miRNAs. In particular, RNAs in which two RNAs containing a miRNA binding sequence are positioned between two double-stranded structures were able to strongly inhibit miRNA. These RNAs can be expressed from, for example, a PolIII promoter, and by integration into a vector, miRNAs can be stably inhibited for a long period of time. | 10-06-2011 |
| 20110237462 | IMMOBILIZATION SUBSTRATE AND METHOD FOR PRODUCING THE SAME - An antibody-fragment-immobilizing substrate includes a substrate and at least one set of antibody fragments, wherein antibody fragments of each set include at least two types of separate antibody fragments, the at least two types of separate antibody fragments include at least one type of labeled antibody fragment having a labeled site labeled with a luminescent substance and at least one type of acceptor antibody fragment having an acceptor site for accepting emission from the labeled antibody fragment, and the at least one type of labeled antibody fragment and the at least one type of acceptor antibody fragment are capable of cooperatively recognizing one type of antigen in combination and are independently immobilized on the substrate in a positional relationship that allows each of the antibody fragments in one set to bind to the same antigen. | 09-29-2011 |
| 20110236725 | MICROBIAL FUEL CELL - It is an object of the present invention to provide a microbial fuel cell capable of increasing a current density without employing a mediator. The microbial fuel cell | 09-29-2011 |
| 20110236679 | IMMOBILIZATION SUBSTRATE AND METHOD FOR PRODUCING THE SAME - An antibody-fragment-immobilizing substrate includes a substrate and at least one set of antibody fragments, wherein the antibody fragments of each set includes at least two types of separate antibody fragments that are capable of recognizing one type of antigen and that are independently immobilized on the substrate in a positional relationship that allows each of the antibody fragments in one set to bind to the same antigen. | 09-29-2011 |
| 20110235883 | THREE-DIMENSIONAL TEMPLATE TRANSFORMATION METHOD AND APPARATUS - A method includes: obtaining designated 3D template for a designated part in a heart; generating 3D annulus data representing an annulus of a heart valve identified as a reference of transformation, from a cross-section image in a plane passing through an axis within the annulus of the identified heart valve in 3D volume data generated from tomographic images; identifying a first point on the annulus of the identified heart valve in the designated 3D template and a second point on the annulus represented by the 3D annulus data; arranging n starting points from the first point on the annulus of the identified heart valve in the designated 3D template and n target points from the second point on the annulus represented by the 3D annulus data; and calculating movement destination coordinates of vertices of polygons relating to the designated 3D template to transform the designated 3D template. | 09-29-2011 |
| 20110234044 | PIEZOELECTRIC/ELECTROSTRICTIVE CERAMIC, MANUFACTURING METHOD FOR PIEZOELECTRIC/ELECTROSTRICTIVE CERAMIC, PIEZOELECTRIC/ ELECTROSTRICTIVE ELEMENT, AND MANUFACTURING METHOD FOR PIEZOELECTRIC/ELECTROSTRICTIVE ELEMENT - Provided is a piezoelectric/electrostrictive ceramic which produces large electric-field induced strain without performing an aging treatment for a long period of time. A piezoelectric/electrostrictive ceramic sintered body in which the ratio of the number of ions at A sites to the number of ions at B sites in a perovskite structure is at least 0.94 to at most 0.99 is subjected to an oxygen heat treatment at a temperature of 600 to 1050° C. for 2 to 100 hours under an atmosphere with an oxygen partial pressure of 0.05 to 1.0 atm. | 09-29-2011 |
| 20110233689 | SEMICONDUCTOR DEVICE, PROCESS FOR PRODUCING SEMICONDUCTOR DEVICE, SEMICONDUCTOR SUBSTRATE, AND PROCESS FOR PRODUCING SEMICONDUCTOR SUBSTRATE - There is provided a semiconductor device that includes a III-V Group compound semiconductor having a zinc-blende-type crystal structure, an insulating material being in contact with the (111) plane of the III-V Group compound semiconductor, a plane of the III-V Group compound semiconductor equivalent to the (111) plane, or a plane that has an off angle with respect to the (111) plane or the plane equivalent to the (111) plane, and an MIS-type electrode being in contact with the insulating material and including a metal conductive material. | 09-29-2011 |
| 20110231112 | System and Method for Damage Diagnosis - The object of the invention is to provide a damage diagnostic system that uses a damage detection system that obtains propagation intensity distribution data, which is expanded in the two dimensions frequency and propagation time, by converting the output value from an oscillation detection sensor that was obtained when oscillation is performed by an oscillator, and for one mode or two or more modes that are selected from the fundamental mode and higher mode of Lamb waves, obtains certain characteristic values from the data, for example three indices, which are the slope of the mode dispersion of the A1 mode (rate of change of the propagation time with respect to the frequency), the amount of decrease in the propagation time of the A1 mode, and the amount of increase in the propagation time of the S0 and S1 modes, and outputs the measurement results. The measurement results are displayed on a display device. | 09-22-2011 |
| 20110224961 | METHOD FOR SYNTHESIZING NUMERICAL OPERATORS, SYSTEM FOR SYNTHESIZING OPERATORS, AND SIMULATION DEVICE - A stiffness matrix H′ is designed as P | 09-15-2011 |
| 20110224545 | ULTRASONIC DIAGNOSIS APPARATUS - An ultrasonic beam ( | 09-15-2011 |
| 20110218453 | Machine control device, machine system, machine control method, and recording medium storing machine control program - A machine control device includes: first decoders for estimating, from brain signal information, which one of body movements a user performs or images, based on learning using pairs of movements performed by the user and brain signal information, the body movements going toward one of first to nth body postures; second decoders for estimating from the brain signal information, an correct rate on the body movement estimation, based on learning using pairs of correct rates of the estimation of body movements and the brain signal information; and electric prosthetic arm control section for controlling an electric prosthetic arm to change stepwise its posture between first to nth postures via at least one intermediate posture therebetween, the first to nth postures corresponding to the first to nth body postures. The first decoders perform the estimation only when the estimated correct rate exceeds a threshold. When the first decoders estimate that the body movements goes toward a body posture different from the current one, the electric prosthetic arm control section changes the posture of the machine by performing a part of substeps of change from one of the first to nth body postures toward the posture associated with the body posture toward which the estimated body movement goes. This configuration allows a user to control a brain-signal-based machine to perform a natural movement without a long-term training and much brain information. | 09-08-2011 |
| 20110218121 | GENE ASSOCIATED WITH LIVER CANCER, AND METHOD FOR DETERMINATION OF THE RISK OF ACQUIRING LIVER CANCER - Provided are a method for detecting early-stage liver cancer and determining a risk of liver cancer by using blood collected from a patient with imposing a less burden on the patient; and a gene marker, a probe, a primer, and a reagent kit that can be used in the detection. A marker for diagnosis of acquiring liver cancer includes a polynucleotide that can detect all of the following methylated genes and a gene region: (1) human SALL3c gene, (2) human ECEL1 gene, and (3) SEQ ID NO: 6 (NT_037622.5, 1393863-1395863). | 09-08-2011 |
| 20110215249 | SIGNAL LIGHT DETECTION DEVICE AND METHOD OF DETECTING SIGNAL LIGHT - An electric signal produced by a photo-electric conversion element( | 09-08-2011 |
| 20110213796 | INFORMATION SEARCH SYSTEM, METHOD, AND PROGRAM, AND INFORMATION SEARCH SERVICE PROVIDING METHOD - A dialogical information search system is realized by comprehensively utilizing different kinds of ontologies: a library classification system and a Wikipedia category. | 09-01-2011 |
| 20110212917 | AGENT FOR AMELIORATING BRAIN HYPOFUNCTION - Provided are effective and highly safe agents, medicaments and the like for ameliorating various disorders caused by brain hypofunction. Also provided is a preventing or ameliorating agent for brain hypofunction containing N-acetyl-D-mannosamine, a pharmaceutical composition for preventing, ameliorating or treating disorders due to brain hypofunction, containing an effective amount of N-acetyl-D-mannosamine and a pharmaceutically acceptable carrier, and a food comprising N-acetyl-D-mannosamine added thereto. | 09-01-2011 |
| 20110204278 | TITANIUM OXIDE PARTICLES, MANUFACTURING METHOD THEREOF, MAGNETIC MEMORY, AND CHARGE STORAGE TYPE MEMORY - There are provided titanium oxide particles capable of manifesting an unprecedented property, a manufacturing method thereof and a magnetic memory as well as a charge storage type memory employing the titanium oxide particles. Unlike-conventional bulk bodies phase-transited between nonmagnetic semiconductors and paramagnetic metals around about 460K, provided are titanium oxide particles | 08-25-2011 |
| 20110193139 | CELL MEASURING DEVICE - There is provided a cell measuring apparatus that can measure cells efficiently. In a cell measuring apparatus | 08-11-2011 |
| 20110192352 | CORAL CULTIVATION METHOD, MANUFACTURING METHOD FOR CORAL-GROWTH SUBSTRATE PRECIPITATED WITH ELECTRODEPOSITED MINERALS, AND CORAL-GROWTH SUBSTRATE - A coral cultivation method includes: an electrodeposited-mineral precipitating procedure for precipitating electrodeposited minerals on a coral-growth substrate for growing coral, which is placed in seawater, by applying an electric current between the coral-growth substrate and a first anode that is electrically connected to the coral-growth substrate and placed in the seawater; a coral-larvae growing procedure for growing coral larvae on the coral-growth substrate precipitated with the electrodeposited minerals; a coral-cultivation-structure configuring procedure for configuring a coral cultivation structure from a plurality of the coral-growth substrates on which the coral larvae are grown; and a coral cultivating procedure for cultivating coral by applying an electric current between the coral-growth substrate on which the coral larvae are grown and a second anode. | 08-11-2011 |
| 20110183000 | ARTIFICIAL BONE MATERIAL HAVING CONTROLLED CALCIUM ION ELUTION - Disclosed is an artificial bone material having controlled calcium ion elution, which does not induce cytotoxicity or any inflammatory response. It is found that the elution of a calcium ion from an artificial bone material for transplantation which contains a calcium-containing substance can be prevented effectively by subjecting the carrier to a surface treatment or adding a surface-treating agent to the carrier. It is also found that the induction of cytotoxicity can be prevented and the induction of an inflammatory response can also be prevented by using the above-mentioned carrier having controlled calcium ion elution. | 07-28-2011 |
| 20110177578 | APTAMER AGAINST IL-17 AND USE THEREOF - The invention provides an aptamer possessing an inhibitory activity against IL-17, as well as a complex comprising an aptamer possessing a binding activity or inhibitory activity against IL-17 and a functional substance (for example, affinity substances, substances for labeling, enzymes, drug delivery vehicles, drugs and the like). The invention also provides a pharmaceutical drug, cell migration inhibitor, diagnostic reagent, detection probe, carrier, labeling agent, and the like comprising the aforementioned aptamer or complex, and methods of detecting and purifying IL-17 by using the aforementioned aptamer or complex. | 07-21-2011 |
| 20110177089 | APOPTOSIS INDUCER - Provided is an agent which is useful for diagnosis, prevention, and treatment of various diseases induced by an oxidative stress. Disclosed are secreted eIF5A protein and a pharmaceutical containing the same. | 07-21-2011 |
| 20110172886 | VEHICLE AND ITS CONTROL METHOD - To provide a vehicle having high operability and its control method. A vehicle includes a passenger seat on which a passenger rides on, a chassis that support the passenger seat, wheels that move the chassis, a force sensor that outputs a measurement signal according to a force exerted on a seat surface of the passenger seat, a drive unit that drives the passenger seat so as to change an angle of the seat surface of the passenger seat, and a control calculation unit that calculates a reference input used to drive the wheels and the drive unit based on a drive amount of the drive unit, a balanced position posture of the passenger seat, and the measurement signal from the force sensor. | 07-14-2011 |
| 20110166854 | METHOD, APPARATUS, PROGRAM AND RECORDING MEDIUM FOR LONG-TERM PREDICTION CODING AND LONG-TERM PREDICTION DECODING - A method and apparatus multiplies a past sample a time lag τ older than a current sample by a quantized multiplier ρ′ on a frame by frame basis, subtracts the multiplication result from the current sample, codes the subtraction result, and codes the time lag using a fixed-length coder if the multiplier ρ′ is smaller than 0.2 or if information about the previous frame is unavailable, or codes the time lag using a variable-length coder if ρ′ is not smaller than 0.2. A multiplier ρ is coded by a multiplier coder and the multiplier ρ′ obtained by decoding the multiplier ρ is outputted. The process is performed for each frame. | 07-07-2011 |
| 20110166672 | BONE DEFECT FILLER NOT ADSORBING BONE GROWTH FACTOR AND NOT INHIBITING THE ACTIVITY OF THE SAME - An object of the invention is to provide a bone filling material capable of promoting the bone regeneration effect of a growth factor such as platelet rich plasma (PRP). | 07-07-2011 |
| 20110166089 | SOLUTION FOR TISSUE ADHESION PREVENTION AND METHOD FOR TISSUE ADHESION PREVENTION - The objective of the invention is to provide a solution for tissue adhesion prevention and a method for tissue adhesion prevention that are applicable to general surgery and in which covering condition during surgery is stable and convenient. The invention is the solution for tissue adhesion prevention of which the active ingredient is trehalose. Also, it contains at least one or more among antioxidants, chelates, antiseptics, hemostatics, anti-inflammatory agents, and polysaccharides, mucopolysaccharides, salts of polysaccharides and salts of mucopolysaccharides having lubricating properties. This solution for tissue adhesion prevention is provided as any form of perfusion fluid, spray fluid, solution for spray or vaporization administration, foam-like aerosol preparation, injection solution for intravenous fluids, intravenous fluid. | 07-07-2011 |
| 20110165730 | METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE - A semiconductor device manufacturing method of stacking semiconductor chips in layers over a semiconductor substrate having, close to its main surface, semiconductor chips, connecting semiconductor chips in different layers to enable signal transmission, and singularizing the layered semiconductor chips into pieces. The method includes steps of forming an insulating layer on the main surface of the semiconductor substrate; stacking the semiconductor chips over the semiconductor chips of the semiconductor substrate in such a manner as to interpose the insulating layer between them and an opposite surface of each disposed semiconductor chip opposes the insulating layer, the opposite surface being opposite to the main surface; forming, in each of the disposed semiconductor chips, a via hole penetrating from the main to the opposite surface; and forming a connection which enables signal transmission between the disposed semiconductor chips and the corresponding semiconductor chips of the semiconductor substrate via the via holes. | 07-07-2011 |
| 20110165179 | THERAPEUTIC AGENTS FOR ALZHEIMER'S DISEASE AND CANCER - To provide a therapeutic drug for Alzheimer's disease and/or a cancer. | 07-07-2011 |
| 20110165085 | TUMOR SELECTIVE FLUORESCENT STAINING AGENT - A tumor cell or tumor tissue-selective fluorescent staining agent comprising a compound represented by the following general formula (I): | 07-07-2011 |
| 20110160700 | DEVICE AND METHOD FOR AUTOMATICALLY PREPARING EMULSION DRUG - In preparation of an emulsion by causing a mixture to flow from one syringe through a connector into another syringe, an object is to prevent the air from being entrained into cylinders and prepare the emulsion containing no air bubble, and another object is to easily prepare a homogeneous emulsion. Provided is a syringe pressing apparatus, including: a syringe fixing mechanism for fixing two syringes to a casing, the two syringes being coupled to each other through a connector; a pressing mechanism for alternately pressing syringe plungers of the two syringes; and a plunger-pressure-measuring device for measuring a pressure with which the pressing mechanism presses the syringe plungers. | 06-30-2011 |
| 20110160456 | HYDROGEN STORAGE MATERIAL - The hydrogen storage material of the invention is a hydrogen storage material comprising metal fine particles with hydrogen storage capacity, and an organic compound that has at least two specific groups that can bind with the metal fine particles, and that is bonded with the metal fine particles by the specific groups. | 06-30-2011 |
| 20110159603 | FLUORESCENT PROBE SPECIFIC TO HYDROGEN PEROXIDE - A compound represented by the following general formula (IA) or (IB) (R | 06-30-2011 |
| 20110152694 | BLOOD-PRESSURE SENSOR, MANUFACTURING METHOD THEREOF, AND BLOOD-PRESSURE SENSOR SYSTEM - A blood-pressure sensor is constituted of an elastic body which is fitted to a blood-vessel outer wall, and a shape of which is deformed by force generated by pulsing motion of expansion and contraction of the blood vessel, and a plurality of nanosized particles dispersedly provided in the elastic body, and when the force is applied to the sensor in a state where the sensor is irradiated with light, the magnitude of the force is measured on the basis of intensity of scattered light from the particles or emission intensity of fluorescence from the particles, the intensity of the scattered light or emission intensity of the fluorescence corresponding to a change in distance between the particles. | 06-23-2011 |
| 20110151456 | TEST METHOD FOR TYPE-2 DIABETES USING GENE POLYMORPHISM - The present invention relates to a method of testing for genetic susceptibility to type-2 diabetes in a subject that comprises detecting one or more polymorphisms present in the KCNQ1 gene and/or EIF2AK4 gene in a DNA-containing sample collected from the subject. The present invention permit a method of accurately, conveniently, and rapidly testing the genetic susceptibility of subjects to type-2 by targeting determinative genetic factors of genetic susceptibility to type-2 diabetes. | 06-23-2011 |
| 20110151260 | SILICA NANOPARTICLE STRUCTURE AND PROCESS FOR PRODUCTION OF SAME - It is an object of the present invention to provide a silica nanoparticle structure and a process for producing the same, which allow silica nanoparticles to be order-controlled to thereby make it possible to extend the application field of the silica nanoparticles ever more markedly. Silica nanoparticle structure components | 06-23-2011 |
| 20110142614 | COUNTER-ROTATING AXIAL FLOW FAN - A counter-rotating axial flow fan with reduced noise at the target operating point achieved without modifying a front impeller, a rear impeller, or a middle stationary portion is provided. An annular rib including a projecting surface for generating turbulent flow is formed on an inner wall portion of a casing at a position off from the middle stationary portion to a side of the rear impeller, the projecting surface extending radially inwardly of the inner wall portion and extending continuously in the circumferential direction of the inner wall portion. A fluid striking the projecting surface for generating turbulent flow is partially disturbed to form a turbulent flow before entering an area in which the rear impeller is provided. The turbulent flow suppresses flow separation of a fluid flowing along the surfaces of rear blades of the rear impeller from the surfaces of the rear blades. | 06-16-2011 |
| 20110142612 | COUNTER-ROTATING AXIAL FLOW FAN - A counter-rotating axial flow fan in which the shape of stationary blades of a middle stationary portion is optimized to reduce noise is provided. Defining the maximum axial chord length of front blades as Lf, the maximum axial chord length of rear blades as Lr, and the maximum axial chord length of stationary blades as Lm, a relationship of Lm/(Lf+Lr)<0.14 is satisfied. Defining the maximum dimension between the blade chord for lower surfaces of the stationary blades and the lower surfaces as K | 06-16-2011 |
| 20110142611 | COUNTER-ROTATING AXIAL FLOW FAN - A counter-rotating axial flow fan with improved characteristics and reduced noise compared to the related art can be provided. Defining the number of front blades as N, the number of stationary blades as M, and the number of rear blades as P, and defining the maximum axial chord length of the front blades as Lf, the maximum axial chord length of the rear blades as Lr, the outside diameter of the front blades as Rf, and the outside diameter of the rear blades as Rr, the counter-rotating axial flow fan satisfies the following two relationships: N≧P>M; and Lf/(Rf×π/N)≧1.25 and/or Lr/(Rr×π/P)≧0.83. | 06-16-2011 |
| 20110134950 | Method of manufacturing semiconductor device - The method of manufacturing the semiconductor device comprises the step of forming quantum dots | 06-09-2011 |
| 20110132231 | CEMENT ADMIXTURE, AND CEMENT COMPOSITION AND CONCRETE CONTAINING THE CEMENT ADMIXTURE - It is an object of the invention to provide a cement admixture that can form concrete having a sufficient self-healing capability and satisfactorily maintaining its self-healing capability for prolonged periods. The cement admixture of the invention contains an expanding material and an alumina-silicate with swelling properties. The cement admixture is combined with cement to form a cement composition. The cement composition is mixed with water and an aggregate to provide concrete with an excellent self-healing capability. | 06-09-2011 |
| 20110132094 | ULTRASONIC PROBE SUPPORT DEVICE - A mounting unit ( | 06-09-2011 |
| 20110130688 | BONE INSPECTING SYSTEM, AND LOWER LEG SUPPORTING DEVICE - Provided is a bone inspecting system for placing the lower legs (L) of an examinee (P) on a proximal support block ( | 06-02-2011 |
| 20110129686 | DEPOSITION METHOD, DEPOSITION APPARATUS, AND LAMINATED FILM - In a deposition method of forming a compound layer including a metal and an oxide by a supercritical fluid deposition method, a first material for generating the metal and a second material for generating the oxide are supplied to a supercritical fluid. With an increase of a thickness of the compound layer, a ratio of a supplied amount of the first material with respect to a supplied amount of the second material is increased. | 06-02-2011 |
| 20110129298 | PHOTOCATALYST MATERIAL, PROCESS FOR PRODUCING THE PHOTOCATALYST MATERIAL, AND METHOD FOR DECOMPOSING CONTAMINANT USING THE MATERIAL - This invention provides a photocatalyst material, which can be produced at low cost without using platinum, particularly a visible light response-type photocatalyst material, a material having a photocatalyst mechanism not possessed by the conventional photocatalyst material, a process for producing the material, and a method for decomposing a contaminant using the material. The photocatalyst material comprises a) an oxide of a first metal and b) an aqua complex salt of a second metal. In this case, for the oxide of a first metal, the redox potential of a conduction band lower end in the oxide is on a rather negative side than 0.2 V (a value as measured at pH=0, vs. reference electrode potential). For the aqua complex salt of a second metal, the redox potential of a second metal ion in the aqua complex salt is on a rather negative side than 3.0 V (a value as measured at pH=0, vs. reference electrode potential). In the material, the aqua complex salt of a second metal is chemically adsorbed on the oxide of a first metal. | 06-02-2011 |
| 20110126794 | WANKEL ROTARY ENGINE | 06-02-2011 |
| 20110126629 | KNEE ACOUSTIC MATCHING DEVICE FOR ULTRASONIC PROBE - An acoustic matching device has a water bag ( | 06-02-2011 |
| 20110123369 | DISPLACEMENT TRANSDUCER - Provided is a displacement amplifying device which uses Pascal's principle and is insusceptible to temperature change. A main body ( | 05-26-2011 |
| 20110117666 | FLUORESCENT PROBE - A fluorescent probe comprising a compound represented as (Fluorophore A)-S-(Fluorophore B) (Fluorophore A and Fluorophore B are fluorophores which emit fluorescence when they are irradiated with an excitation light of a wavelength of 600 to 950 nm, Fluorophore A has a property that it shows change of fluorescence characteristic before and after a specific reaction with an substance to be measured, and S represents a spacer which connects Fluorophore A and Fluorophore B), which compound shows substantial change in efficiency of fluorescence resonance energy transfer between Fluorophore A and Fluorophore B before and after the specific reaction with the objective substance, wherein Fluorophore A is represented by the following formula (AI): | 05-19-2011 |
| 20110111515 | REAGENT FOR MEASUREMENT OF REACTIVE OXYGEN - A reagent for measurement of reactive oxygen, which can be used with a light of the near infrared region showing superior biological tissue permeability, wherein (i) a first cyanine compound residue and a second cyanine compound residue are bound to each other, (ii) the first cyanine compound residue has a property that it easily reacts with a reactive oxygen species and is thereby decomposed, and (iii) the second cyanine compound residue either equals or surpasses the first cyanine compound residue in its stability to the reactive oxygen species, and the first cyanine compound residue acts as a quenching group for the second cyanine compound residue. | 05-12-2011 |
| 20110098579 | BLOOD-PRESSURE SENSOR SYSTEM - There is provided a blood-pressure sensor system wherein a blood-pressure sensor including a plurality of structures which induces surface plasmon resonance on a light-receiving plane of a photoelectric conversion element is attached to an outer wall of a blood vessel, in which if the blood-pressure sensor is deformed according to expansion or contraction of the blood vessel, an interval of layout of the structure is changed (widened or narrowed), so that an incident form of light with respect to the structures is changed to cause the output from the photoelectric conversion element to be changed. The output is measured as an open circuit voltage, and index calculation is performed, so that a blood pressure value is measured. | 04-28-2011 |
| 20110097793 | CELL SEPARATION DEVICE, CELL SEPARATION SYSTEM AND CELL SEPARATION METHOD - A cell separation device which can perform a continuous processing without bonding fluorescent molecules or magnetic particles to the surface of the cell membrane, a cell separation system, and a cell separation method, wherein when a sample cell suspension containing the desired target cells is supplied continuously from a sample inlet and physiological saline is supplied continuously from a physiological saline inlet, the sample cell suspension flows together with the physiological saline in a liquid flow path and an adsorption force acts on the target cells due to affinity bonding from the adsorbing portions of adsorbing regions in the form of strips formed in a planar wall portion. Since the adsorbing regions in the form of strips are disposed in an asymmetric fashion to the flow path direction of the liquid flow path, the adsorption force acting on the target cells has a constituent perpendicular to the flow path direction. As a result, the target cells shown in | 04-28-2011 |
| 20110081356 | ANTI-CANCER DRUG - The present invention is directed to an anti-cancer drug containing an anti-MFG-E8 antibody as an active ingredient, and to an anti-cancer drug which employs an anti-MFG-E8 antibody in combination with a cancer therapy employing an anti-cancer agent other than the anti-MFG-E8 antibody. | 04-07-2011 |
| 20110077792 | METHOD FOR CONTROLLING DISTRIBUTED POWER SOURCES - A control method of the present invention is a control method for distributed power sources which systematically controls a plurality of distributed power sources having different responsive capabilities for a load disturbance. The distributed power sources include an electricity storage device. The control method of the present invention includes: obtaining a component to be compensated for using a power source having a responsive capability equal to or lower than that of the electricity storage device based on a difference value between a remaining capacity of the electricity storage device and a target remaining capacity; and compensating for the component to be compensated for using the power source having a responsive capability equal to or lower than that of the electricity storage device. | 03-31-2011 |
| 20110077416 | COMPOUND COMPRISING TRIARYLAMINE MOIETIES AND A CONDENSED RING MOIETY, AND THE PRODUCTION METHOD THEREOF - The present invention provides a compound having absorbing and luminescence wavelengths at relatively longer wavelength side of the visible area, and having thermal stability, which acts as a dye and/or a luminescence material and has practical utility therefor, and a production method thereof. The above subject of the present invention can be solved by a compound represented by general formula I: R | 03-31-2011 |
| 20110063626 | DETECTION METHOD OF CRACK OCCURRENCE POSITION - A surface layer ( | 03-17-2011 |
| 20110059176 | MATERIAL FOR PREVENTING TISSUE ADHESION AND MATERIAL FOR PREVENTING JOINT CONTRACTURE - The present invention provides a tissue adhesion prevention material preparable at an affected area at the time of surgical procedure by producing a three-dimensional polymeric structure having a flexible structure and high solute permeability in a medium comprising water as the main component under mild conditions appropriate for body tissue components (i.e., at ordinary temperature and pressure) without conducting a chemical reaction or employing a physical procedure such as heating or light or radiation irradiation. This makes it possible to provide a tissue adhesion prevention material and a joint contracture prevention materials, which can effectively prevent postoperative adhesion of a tissue in the affected area to the surrounding tissue and contracture of the movable part of a joint. | 03-10-2011 |
| 20110058685 | METHOD OF SEPARATING SOUND SIGNAL - The present invention obtains a separated signal from an audio signal based on the anisotropy of smoothness of spectral elements in the time-frequency domain. A spectrogram of the audio signal is assumed to be a sum of a plurality of sub-spectrograms, and smoothness of spectral elements of each sub-spectrogram in the time-frequency domain has directionality on the time-frequency plane. The method comprises obtaining a distribution coefficient for distributing spectral elements of said audio signal in the time-frequency domain to at least one sub-spectrogram based on the directionality of the smoothness of each sub-spectrogram on the time-frequency plane, and separating at least one sub-spectrogram from said spectral elements of said audio signal using said distribution coefficient. | 03-10-2011 |
| 20110053267 | METHOD FOR PREPARATION OF PLATELET FROM iPS CELL - It is an object of the present invention to provide a method for efficiently preparing blood cells, such as mature megakaryocytes and platelets, from iPS cells in an in vitro culture system. | 03-03-2011 |
| 20110045169 | FILM DISPERSED OF CARBON NANOTUBES AND LIGHT EMITTING BODY - Disclosed is a film of dispersed carbon nanotubes that emit intensive light with a particular wavelength. The film of dispersed carbon nanotubes is a film in which a plurality of carbon nanotubes are dispersed in a transparent binder, and each carbon nanotube is dispersed isolatedly in an oriented manner. | 02-24-2011 |
| 20110044362 | LIGHT EMITTING DEVICE - A light-emitting device having a ring optical resonator and capable of laser oscillation by a novel structure realized by working out the mechanism of light emission. The light-emitting device having a ring optical resonator fabricated on a base is characterized in that the optical resonator has a core made of a semiconductor and serving to propagate light and a clad formed on at least the base side of the core in the stack direction out of the base side and the opposite side of the core, at least the ring inner and outer peripheral surfaces of the core are covered with a transparent body having an index of refraction lower than that of the space or the clad, and a part of the ring inner and outer peripheral surfaces of the clad are covered with a transparent body having an index of refraction lower than that of the space or the clad. | 02-24-2011 |
| 20110040106 | ORGANIC SEMICONDUCTOR COMPOUND, SEMICONDUCTOR ELEMENT, SOLAR BATTERY, AND PROCESS FOR PRODUCING ORGANIC SEMICONDUCTOR COMPOUND - Disclosed is, for example, a compound that can be a material which can control many functions. According to a first aspect of the present invention, there is provided an organic semiconductor compound characterized in that the organic semiconductor compound is produced by forming a salt of organic molecules as a donor with an inorganic acid or an inorganic base and causes self-accumulation. According to the above constitution, the organic semiconductor compound can be obtained in a simple manner. According to a second aspect of the present invention, there is provided an organic compound characterized by being produced by deriving an ammonia salt or a hydroxyamine salt from a compound having a tetrathiafulvalene analogue site in the skeleton thereof and containing a protonic acid functional group. According to the above constitution, an organic compound which can control many functions can be obtained. | 02-17-2011 |
| 20110033365 | PROCESS AND APPARATUS FOR PRODUCING CARBONACEOUS FILM - This invention provides a process and apparatus for producing a carbonaceous film such as a DLC film using a solid raw material without the need to supply a high energy radiation such as a laser beam. The process comprises providing a solid organic material as a raw material, applying a discharge energy to the material to form plasma, and depositing the plasma onto a base material to form a carbonaceous film. This process is preferably carried out by using a film production apparatus ( | 02-10-2011 |
| 20110030779 | SILICON SOLAR CELL - A silicon solar cell includes a silicon substrate ( | 02-10-2011 |
| 20110027926 | Optical semiconductor device having diffraction grating disposed on both sides of waveguide and its manufacture method - An active layer ( | 02-03-2011 |
| 20110026679 | X-RAY METERING APPARATUS, AND X-RAY METERING METHOD - An X-ray waveform is generated by validating detection data corresponding to when an X-ray ( | 02-03-2011 |
| 20110021671 | COMPOSITE MATERIAL COMPRISING REGENERATED CELLULOSE AND SYNTHETIC POLYMER AS SOLID COMPONENTS AND PROCESS FOR PRODUCTION OF THE MATERIAL - A composite material comprising regenerated cellulose and a synthetic polymer, both of which are compounded with each other on the order of nanometers, and having both excellent qualities inherent in the cellulose and those inherent in another polymer; and a process for production of the material. A composite material which comprises regenerated cellulose and a synthetic polymer as solid components, wherein fine fibers of the regenerated cellulose form a continuous region and the synthetic polymer is arranged around the fine fibers and the mean diameter of the fine fibers is 1 μm or below, preferably 100 nm or below, still preferably 50 nm or below. | 01-27-2011 |
| 20110018033 | SEMICONDUCTOR WAFER, SEMICONDUCTOR DEVICE, AND METHOD OF MANUFACTURING A SEMICONDUCTOR DEVICE - It is an objective of the present invention to form a favorable interface between an oxide layer and a group 3-5 compound semiconductor using a practical and simple method. | 01-27-2011 |
| 20110013749 | HIGH BRIGHTNESS X-RAY GENERATING DEVICE AND METHOD - A high brightness X-ray generator and a high brightness X-ray generating method are provided which are able to promote an increase in X-ray brightness (i.e., an increase in an X-ray output) while suppressing an excessive increase in the cost of optical elements such as a laser unit, a mirror, and a lens. A high brightness X-ray generator generates an X-ray by inverse Compton scattering by colliding an electron beam with pulse laser light. There are provided a plurality of pulse laser units ( | 01-20-2011 |
| 20110012175 | SEMICONDUCTOR WAFER, SEMICONDUCTOR WAFER MANUFACTURING METHOD, AND ELECTRONIC DEVICE - A high-quality GaAs-type crystal thin film using an inexpensive Si wafer with good thermal release characteristics is achieved. Provided is a semiconductor wafer comprising an Si wafer; a Ge layer that is crystal-grown on the wafer and shaped as an isolated island; and a functional layer that is crystal-grown on the Ge layer. The Ge layer may be shaped as an island having a size that docs not exceed double a distance moved by crystal defects as a result of annealing the Ge layer at a certain temperature for a certain time. The Ge layer may be shaped as an island having a size for which stress due to a difference relative to a thermal expansion coefficient of Si, which is material of the wafer, does not cause crystal dejects when the Ge layer is annealed at a certain temperature. | 01-20-2011 |
| 20110011459 | HYBRID AND/OR COMPLEX MATERIAL, PHOTOELECTRIC CONVERSION MATERIAL, DYE-SENSITIZED SOLAR CELL, DYE-SENSITIZED SOLAR CELL DEVICE, MANUFACTURING METHOD OF PHOTOELECTRIC CONVERSION DEVICE, AND METHOD OF ANALYZING TITANIUM OXIDE CRYSTAL STRUCTURE - There is provided a hybrid and/or complex material or the like which can realize a high-efficient photoelectric conversion material or the like. One aspect of the present invention lies in a dye-sensitized solar cell device | 01-20-2011 |
| 20110010319 | CORRESPONDENCE LEARNING APPARATUS AND METHOD AND CORRESPONDENCE LEARNING PROGRAM, ANNOTATION APPARATUS AND METHOD AND ANNOTATION PROGRAM, AND RETRIEVAL APPARATUS AND METHOD AND RETRIEVAL PROGRAM - An image data processing system has a learning storage apparatus that stores projection matrixes obtained by canonical correlation analysis so as to derive, based on at least one of an image feature and a word feature, a latent variable as an abstract concept used for associating an image with a word corresponding thereto and that further stores information required for obtaining the latent variable acquired by use of the projection matrixes, a probability of occurrence of an arbitrary image feature from a certain latent variable and a probability of occurrence of an arbitrary word feature from a certain latent variable. In this way, a probability of the image feature and word feature being simultaneously outputted can be easily and quickly determined, thereby executing a high-speed annotation or retrieval with high precision. | 01-13-2011 |
| 20110007875 | DEVICE AND METHOD FOR ADJUSTING COLLISION TIMING BETWEEN ELECTRON BEAM AND LASER LIGHT - An electron beam detection device ( | 01-13-2011 |
| 20110006399 | SEMICONDUCTOR WAFER AND SEMICONDUCTOR WAFER MANUFACTURING METHOD - A high-quality GaAs-type crystal thin film using an inexpensive Si wafer with good thermal release characteristics is achieved. Provided is a semiconductor wafer comprising a single-crystal Si wafer; an insulating layer that has an open region and that is formed on the wafer; a Ge layer that is epitaxially grown on the wafer in the open region; and a GaAs layer that is epitaxially grown on the Ge layer, wherein the Ge layer is formed by (i) placing the wafer in a CVD reaction chamber that can create an ultra-high vacuum low-pressure state, (ii) performing a first epitaxial growth at a first temperature at which raw material gas can thermally decompose, (iii) performing a second epitaxial growth at a second temperature that is higher than the first temperature, (iv) performing a first annealing, at a third temperature that is loss than a melting point of Ge, on epitaxial layers formed by the first and second epitaxial growths, and (v) performing a second annealing at a fourth temperature that is lower than the third temperature. The Ge layer may he formed by repeating the first annealing and the second annealing a plurality of times, and the insulating layer may be a silicon oxide layer. | 01-13-2011 |
| 20110005916 | PHOTOCATALYST MATERIAL, METHOD FOR DECOMPOSITION OF ORGANIC MATERIAL, INTERIOR MEMBER, AIR PURIFICATION DEVICE, AND APPARATUS FOR PREPARATION OF OXIDIZING AGENT - The present invention provides a tungsten trioxide microparticle carrying on its surface divalent copper salt. The divalent copper salt is utilized to perform a multi-electron reduction of oxygen. The tungsten trioxide exhibits a high oxidative decomposition activity when exposed to visible light. | 01-13-2011 |
| 20110004003 | Compound, Photochromic Material, Electronic Material, Compound Producing Method, 2,3-BIS(N,N-BIS(P-ANISYL)4-Minophenylethynyl)Dimethylfumarate Producing Method and 2,3-BIS(N,N-BIS(P-ANISYL)4-Aminophenylethynyl)Dimethylmaleate Producing method - A novel high-performance material is provided. A certain aspect of the present invention lies in a 2,3-bis(N,N-bis(p-anisyl)4-aminophenylethynyl)dimethylfumarate producing method, characterized by illuminating light onto 2,3-bis(N,N-bis(p-anisyl)4-aminophenylethynyl)dimethylmaleate. Also, a further certain aspect of the present invention lies in a 2,3-bis(N,N-bis(p-anisyl)4-aminophenylethynyl)dimethylmaleate producing method, characterized by illuminating light onto 2,3-bis(N,N-bis(p-anisyl)4-aminophenylethynyl)dimethylfumarate. According to this constitution, there can be obtained a high-performance material by a simple technique. | 01-06-2011 |
| 20110003980 | Oligo-Aminosaccharide compound - An oligo-aminosaccharide compound formed by binding 3 to 6 saccharides, such as 2,6-diamino-2,6-dideoxy-α-(1→4)-D-glucopyranose oligomers, or a salt thereof, which has high affinity to a double-stranded nucleic acid. | 01-06-2011 |
| 20110002083 | CERAMIC MATERIAL AND ELECTRONIC DEVICE - A ceramic material has a perovskite structure and is represented by formula of (1−x)ABO | 01-06-2011 |
| 20100331244 | PHARMACEUTICAL COMPOSITION, FOOD OR DRINK, AND METHODS RELATED THERETO - A pharmaceutical composition including, as an active ingredient, one of the following proteins (I) and (II): (I) an apoptosis inhibitor of macrophage; and (II) a protein which consists of an amino acid sequence having deletion, substitution, or addition of one or more amino acids in an amino acid sequence of the apoptosis inhibitor of macrophage and having homology to the amino acid sequence of the apoptosis inhibitor of macrophage, and has a function of inhibiting the differentiation of preadipocytes to mature adipocytes and/or a function of inducing lipolysis in the mature adipocytes. | 12-30-2010 |
| 20100323364 | MODIFIED tRNA CONTAINING UNNATURAL BASE AND USE THEREOF - In the method for introducing a noncanonical amino acid residue into a desired position in a protein, the structure of tRNA is so modified as to have improved affinity for aminoacyl-tRNA synthetase or improved specificity to aminoacyl-tRNA synthetase. An unnatural base is contained at any position in tRNA, whereby the efficiency of aminoacylation of the tRNA with a noncanonical amino acid can be improved. | 12-23-2010 |
| 20100317032 | METHOD FOR DETECTING ANTIGEN AND ANTIGEN DETECTION DEVICE - Provided is a method for detecting an antigen in a sample, the method including: bringing an unlabeled polypeptide and a labeled polypeptide into contact with an antigen in a sample, the unlabeled polypeptide being one of a pair including a VH-region polypeptide and a VL-region polypeptide which are separate and capable of cooperatively recognizing the antigen, and the labeled polypeptide being the other of the pair including the separate VH-region polypeptide and the VL-region polypeptide and being labeled with an environmentally-responsive substance at a site where the environmentally-responsive substance does not inhibit binding of the antigen, and detecting a change in the environmentally-responsive substance caused by a change in the environment around the labeled polypeptide after the contact. Also provided is an antibody fragment polypeptide set including the unlabeled polypeptide and the labeled polypeptide. | 12-16-2010 |
| 20100316568 | DIAGNOSTIC AGENT AND THERAPEUTIC AGENT FOR PANCREATIC CANCER - The present invention provides a novel diagnostic or therapeutic method for pancreatic cancer employing a blood marker. The present invention provides a diagnostic or therapeutic drug for pancreatic cancer containing an anti-AMIGO2 antibody. | 12-16-2010 |
| 20100311608 | METHOD TO PREPARE MAGNETIC BEADS CONJUGATED WITH SMALL COMPOUNDS - It is an object of the present invention to provide a method for stably and efficiently binding a compound to magnetic beads. The present invention relates to a method for producing compound-bound magnetic beads, which comprises: allowing a compound to come into contact with magnetic beads, on the surface of each of which a photoreactive compound has bound; extending the magnetic beads together with the compound on a support; and applying light to the magnetic beads to form a covalent bond between the photoreactive compound and the compound. | 12-09-2010 |
| 20100308376 | SEMICONDUCTOR WAFER, SEMICONDUCTOR WAFER MANUFACTURING METHOD, AND ELECTRONIC DEVICE - A high-quality GaAs-type crystal thin film using an inexpensive Si wafer with good thermal release characteristics is achieved. Provided is a semiconductor wafer comprising an Si wafer; an inhibiting layer that is formed on the wafer and that inhibits crystal growth, the inhibiting layer including a covering region that covers a portion of the wafer and an open region that does not cover a portion of the wafer within the covering region; a Ge layer that is crystal-grown in the open region; and a functional layer that is crystal-grown on the Ge layer. The Ge layer may be formed by annealing with a temperature and duration that enables movement of crystal defects, and the annealing is repeated a plurality of times. | 12-09-2010 |
| 20100304980 | PLANAR LIPID BILAYER ARRAY FORMED BY MICROFLUIDIC TECHNIQUE AND METHOD OF ANALYSIS USING PLANAR LIPID BILAYER - There is provided a planar lipid bilayer array formed by microfluidic technique and a method of analysis using the planar lipid bilayers, providing the advantages such as portability, decreased analysis time, a smaller amount of required reagents, and parallel automation with high reproducibility. The planar lipid bilayer array formed by microfluidic technique is a planar lipid bilayer array formed by microfluidic technique (PDMS device) | 12-02-2010 |
| 20100297681 | FLUORESCENT PROBE FOR MEASUREMENT OF GLUCURONATE TRANSFERASE - A fluorescent probe for measurement of UDP-glucuronosyltransferase, which comprises a fluorescein derivative, wherein in the fluorescein derivative, the 2-carboxy group on the benzene ring of fluorescein is replaced with another monovalent substituent, provided that said substituent is a substituent other than sulfo group, and the substituent does not have carboxy group or sulfo group, and wherein the fluorescein derivative may have an arbitrary substituent at a position on the benzene ring other than the 2-position, and the fluorescein derivative may have a substituent selected from the group consisting of an alkoxy group and a halogen atom at the 2-position and/or the 7-position of fluorescein. | 11-25-2010 |
| 20100292408 | PROCESS FOR PREPARING END-MODIFIED VINYLIDENE FLUORIDE ELASTOMER - The present invention provides a preparation process for converting to a vinylidene fluoride elastomer having a group having sulfinic acid, sulfinic acid derivative, sulfonic acid or sulfonic acid derivative at one end or both ends of its trunk chain, and the preparation process provides a vinylidene fluoride elastomer having, at one end or both ends of its trunk chain, end groups represented by the formula: —CR | 11-18-2010 |
| 20100285515 | FLUORESCENT PROBE - A compound represented by the following general formula (I): | 11-11-2010 |
| 20100279398 | INSTRUMENT AND METHOD FOR TREATING MINOR AMOUNT OF BIOLOGICAL MATERIAL - Provided is a technique for handling a minor amount of a biological material with the purpose of observing selectively the interaction between single cells by controlling cell number and two- or three-dimensional configurations of each of the different cell types. The present invention provides an instrument and a method for handling a minor amount of a biological material. The instrument of the present invention for handling a minor amount of a biological material comprises a construct and a base, wherein: the base holds the construct in a releasable manner; the construct is held on a surface of the base in such a manner that a part of the construct is exposed externally on the outer face of the instrument; and at least a part of a surface of the constructs is exposed externally on the outer face of the instrument being fabricated so as to allow the adhesion of the minor amount of the biological material thereto. | 11-04-2010 |
| 20100265074 | INATTENTIVE STATE DETERMINATION DEVICE AND METHOD OF DETERMINING INATTENTIVE STATE - An inattentive state determination device includes an observed amount acquiring means for acquiring information on the driver's line of sight and at least one of either information on driving operations or information on the traveling state as an observed amount; and an inattentive state determining means for determining the inattentive state of the driver based on the stochastic relationship between the inattentive state and the observed amount as well as the observed amount acquired by using the observed amount acquiring means. In addition, the inattentive state determining means calculates the probability that the driver is driving inattentively and determines that the driver is driving inattentively when the calculated probability exceeds a threshold. | 10-21-2010 |
| 20100262376 | APPARATUS, METHOD AND PROGRAM FOR ANALYZING NUCLEIC ACID BASE SEQUENCE AND BASE MODIFICATION - Provided is an apparatus by which a nucleic acid may be analyzed quickly and precisely. Specifically, provided is an apparatus for analysis of a nucleic acid including: a processing unit for creating, based on a total base composition of a nucleic acid, a plurality of base composition sets, creating a hierarchical structure in which the base composition sets are hierarchized in ascending order of a number of bases in a partial base composition at a terminal position, and further creating connection relations between each of the base composition sets, and another base composition set having, at the terminal position, a partial base composition obtained by adding one base to a partial base composition at the terminal position of each of the base composition sets; a processing unit for calculating, for each of the partial base compositions, a predicted mass value of a corresponding product ion, and imparting a weight to each of the base composition sets based on a comparison between the predicted mass value and an actual mass value of a product ion derived from the nucleic acid; and a processing unit for selecting one of base composition sets belonging to each hierarchy while following the connection relations from an outermost hierarchy in the hierarchical structure, based on a weight imparted to each of the base composition sets, to thereby determine a base sequence sequentially from a terminal base of the nucleic acid. | 10-14-2010 |
| 20100262259 | PROCESS FOR PRODUCING BONE GRAFTING MATERIAL, BONE GRAFTING MATERIAL, THREE-DIMENSIONAL SUPPORT FOR CELL CULTURE, AND SEPARATION SUPPORT FOR CHROMATOGRAPHY - A novel method for producing a bone filling material is provided. The method comprises the steps of: (a) kneading ingredient comprising calcium-based material and material comprising binder; (b) molding a predetermined shape of the mixture obtained in step (a) with an injection molding machine having a mold; (c) removing the binder contained in the mold formed in step (b) (i.e., degreasing) to obtain a degreased body; (d) and heating and sintering the degreased body obtained in step (c) to obtain a sintered body. | 10-14-2010 |
| 20100262237 | Biomaterial, Joint Prosthesis Using the Biomaterial and Method of Producing the Same - The object of the present invention is to provide a joint prosthesis, bearing material and a production method thereof, which suppresses wear in a sliding section and suppresses the production of abrasive powder even during repeated daily operation. To achieve the object, there is provided a biomaterial comprising: a substrate made of metal, alloy or ceramic; and a biocompatible material layer laminated on the substrate, wherein hydroxyl groups are formed on the substrate by surface-treating, while the biocompatible material layer comprises a polymer containing phosphorylcholine groups, the substrate and the biocompatible material layer are bound via a binder layer which is combined with the hydroxyl groups of the substrate and with the biocompatible material layer. | 10-14-2010 |
| 20100261920 | AMIDE COMPOUND AND BACTERIAL DISEASE CONTROL AGENT FOR AGRICULTURAL AND HORTICULTURAL USE - The present invention provides an amide compound having antibacterial activity, and a bacterial infection control agent for agricultural and horticultural use that contains the amide compound. The novel amide compound of the present invention is represented by General Formula (1): | 10-14-2010 |
| 20100251702 | Heat Recovery System - A plurality of flat tubes formed as a tube having notches by linearly cutting upper and lower parts from a hollow flat circular doughnut shape are stacked to structure a tube laminate. It is attached to a case so that a notch aligns with the notch and faces upward by an exhaust inflow end plate and that a notch aligns with the notch and faces downward by an exhaust outflow end plate. A cutoff valve is provided at an exhaust outflow end of an exhaust communication tube passing through the center of the tube laminate by heat insulation. While an internal combustion engine is warming up, the cutoff valve is closed to cause the exhaust to flow in gaps of the respective flat tubes from upward to downward as a whole and also a heat exchange medium is caused to flow in the respective flat tubes from downward to upward as a whole to have heat exchanged between the exhaust and the heat exchange medium to recover the exhaust heat. | 10-07-2010 |
| 20100239506 | METHODS FOR DETECTION AND DETERMINATION OF VITAMIN C BY LUMINESCENCE - The present invention provides a method for detection or determination of vitamin C by luminescence that employs a redox-responsive fluorogenic probe consisting of porphyrin or phthalocyanine with a nitroxide radical(s), or that employs a liposome preparation comprising the said redox-responsive fluorogenic probe. The present method can overcome the problems of prior art methods, and in particular, are applicable for bioimaging to allow elucidation of the behavior of vitamin C in vivo. | 09-23-2010 |
| 20100227804 | GEL-FORMING COMPOSITION FOR MEDICAL USE, ADMINISTRATION DEVICE FOR THE COMPOSITION, AND DRUG RELEASE CONTROLLING CARRIER - It is an object of the present invention to provide a gel-forming composition which permits on-site administration and can form a gel exhibiting prescribed strength and sustained drug release, devices for the administration thereof, and a kit for medical use. A gel-forming composition which is composed of the first composition comprising a drug, a first gelling agent represented by the general formula (I) and the like, and the first diluent and the second composition comprising the second gelling agent represented by the general formula (I) and the like and the second diluent; and application devices and kits for medical use, which can hold the gel-forming composition. X | 09-09-2010 |
| 20100225900 | OPTICAL-FIBER-CHARACTERISTIC MEASURING DEVICE AND OPTICAL-FIBER-CHARACTERISTIC MEASURING METHOD - A measurement precision is improved and a measurement range is extended by efficiently suppressing a noise level of integrated unnecessary components from non-correlation positions. Measuring means | 09-09-2010 |
| 20100221807 | CELLULASE ENZYME AND METHOD FOR PRODUCING THE SAME - This invention provides a cellulase enzyme derived from intestinal symbiotic protists of insects selected from the group consisting of | 09-02-2010 |
| 20100219359 | SIGNAL WAVEFORM MEASURING APPARATUS AND MEASURING METHOD - A signal waveform measuring apparatus | 09-02-2010 |
| 20100205745 | AIR CELL - An object of the present invention is to provide an air cell which is capable of detecting that the upper end side and the lower end side of the air bag are nearer than a predetermined distance. | 08-19-2010 |
| 20100197016 | Structure enclosing hematopoietic progenitor cells from ES cells and method for preparing blood cells using the same - An object of the present invention is to provide a sac-like structure enclosing hematopoietic progenitor cells and a method for preparing the sac-like structure as well as a method for efficiently preparing blood cells such as mature megakaryocytes and platelets from the sac-like structure. The present invention provides a sac-like structure enclosing hematopoietic progenitor cells, the sac-like structure being obtained by plating ES cells onto feeder cells and culturing the ES cells under suitable conditions for inducing hematopoietic progenitor cell differentiation. Moreover, the present invention provides a method for producing various blood cells, the method comprising further culturing hematopoietic progenitor cells enclosed in the sac-like structure under suitable conditions for inducing blood cell differentiation. | 08-05-2010 |
| 20100194757 | FUNDUS OCULI OBSERVATION DEVICE, OPHTHALMOLOGIC IMAGE PROCESSING DEVICE, AND PROGRAM - A fundus oculi observation device capable of defining which part in the result of analysis of the layer thickness of a fundus oculi is a part obtained by analyzing a vascular region is provided. A fundus oculi observation device | 08-05-2010 |
| 20100192974 | METHOD FOR ULTRASONIC CLEANING OF CONTAMINATION ATTACHED TO A SURFACE OF AN OBJECT - An ultrasonic cleaning method in which ultrasonic cleaning of a contamination attached to a surface of an object to be cleaned is performed by directing toward the object to be cleaned, a cleaning liquid to which ultrasonic waves are applied by alternately focusing first ultrasonic waves having a frequency of 1 to 10 MHz and second ultrasonic waves having a frequency equal to or lower than ½ of that of the first ultrasonic waves. A focus position adjustment device is used to adjust the distance of the focus position relative to the surface of the object to be cleaned, and a moving device is used to movie at least one of the ultrasonic wave generation device and a support base for the object so that the effect of the ultrasonic waves generated by the ultrasonic wave generation device on the surface of the object to be cleaned is uniform. | 08-05-2010 |
| 20100190019 | Material for curable solvent-based topcoating material, and coating material and coating film comprising or formed from the same - [Object] To provide a coating material for a curable solvent-based topcoating material, having excellent marring resistance, chipping resistance, producing no crack and excellent in performances such as weatherability, stain resistance, adhesion and the like, and a curable solvent-type topcoating material using such a material. | 07-29-2010 |
| 20100184934 | POLYROTAXANE HAVING MAIN CHAIN BACKBONE ESSENTIALLY COMPOSED OF -Si-O- AND METHOD FOR PRODUCING THE SAME, AND CROSSLINKED POLYROTAXANE OBTAINED BY CROSSLINKING THE POLYROTAXANE AND METHOD FOR PRODUCING THE SAME - Disclosed are a novel polyrotaxane having a main chain backbone essentially composed of —Si—O—, and a method for producing such a novel polyrotaxane. Also disclosed are a polyrotaxane having stretchability and/or viscoelasticity, while exhibiting oxygen permeability, heat resistance, chemical resistance, environmental resistance and/or durability, and a method for producing such a polyrotaxane. Further disclosed are a crosslinked polyrotaxane obtained by crosslinking the polyrotaxane with another polymer and/or polyrotaxane through a chemical bond, and a method for producing such a crosslinked polyrotaxane. Specifically disclosed is a polyrotaxane obtained by arranging blocking groups on both ends of a pseudopolyrotaxane, wherein a linear molecule passes through the open portion of a circular molecule in a skewering manner, for preventing elimination of the circular molecule from the linear molecule. In this polyrotaxane, the linear molecule has a main chain backbone essentially composed of —Si—O—. | 07-22-2010 |
| 20100176478 | SEMICONDUCTOR DEVICE AND METHOD FOR MANUFACTURING THE SAME - Provided are a novel method and a novel structure for bringing a Ge or SiGe compound and a metal into ohmic contact with each other. A semiconductor device is provided with a portion composed of only i) Ge or SiGe compound, ii) a metal, and iii) an insulator or a semiconductor arranged between the material i) and the metal ii). In the semiconductor device, A) the material i) and the metal ii) have Schottky junction in the case where the holes of the material i) are majority carriers, and/or B) the material i) and the metal ii) are in an ohmic contact when the electrons of the material i) are majority carriers. | 07-15-2010 |
| 20100176387 | ORGANIC THIN-FILM TRANSISTOR AND METHOD FOR MANUFACTURING THE SAME - An organic thin-film transistor of the present invention has a gate electrode, a gate insulating film, a source electrode, a drain electrode, and an organic semiconductor layer provided above a substrate, and further has a thiol compound layer composed of a benzenethiol compound and provided on a surface of the source electrode and a thiol compound layer composed of a benzenethiol compound and provided on a surface of the drain electrode. This makes it possible to provide an organic thin-film transistor whose threshold voltage can be selectively controlled without greatly affecting a current characteristic other than the threshold voltage. | 07-15-2010 |
| 20100172555 | FEATURE QUANTITY SELECTION METHOD, FEATURE QUANTITY SELECTION APPARATUS, IMAGE CLASSIFICATION METHOD, IMAGE CLASSIFICATION APPARATUS, COMPUTER PROGRAM, AND RECORDING MEDIUM - A control unit ( | 07-08-2010 |
| 20100171066 | MAGNETIC IRON OXIDE PARTICLE, MAGNETIC MATERIAL, AND RADIO WAVE ABSORBER - Disclosed is a magnetic material having high Hc and High Curie point, which is capable of controlling such magnetic characteristics without requiring rare or expensive raw materials. Specifically disclosed is a magnetic material composed of particles of a magnetic iron oxide which is represented by the following general formula: ε-A | 07-08-2010 |
| 20100168430 | MULTIKINASE INHIBITOR - It is intended to provide a compound represented by the formula (1): | 07-01-2010 |
| 20100168380 | PROCESS FOR SYNTHESIZING CYCLIC PEPTIDE COMPOUND - The objective is to provide a novel process for synthesizing a cyclic peptide compound. It is also an objective to provide a novel cyclic peptide compound. The novel process for synthesizing a cyclic peptide compound comprises the steps of: (1) translationally synthesizing a non-cyclic peptide compound having in a molecule a functional group 1 and a functional group 2, which are a pair of functional groups capable of reacting to form a bond, and (2) cyclizing the non-cyclic peptide compound by the reaction of the functional groups 1 and 2 to form a bond. The novel cyclic peptide compound can be synthesized by the process. | 07-01-2010 |
| 20100163931 | GROUP III-V NITRIDE LAYER AND METHOD FOR PRODUCING THE SAME - There is disclosed a hexagonal Group III-V nitride layer exhibiting high quality crystallinity capable of improving the properties of a semiconductor device such as a light emitting element. This nitride layer is a Group III-V nitride layer belonging to hexagonal crystal formed by growth on a substrate having a different lattice constant, which has a growth-plane orientation of {1-100} and in which a full width at half maximum b | 07-01-2010 |
| 20100159278 | MATERIAL FOR ROOM TEMPERATURE DRYING AQUEOUS OVERCOATING MATERIAL AND COATING MATERIAL USING SAME - There is provided a room-temperature drying aqueous overcoating medium containing 1 to 100 mass % of hydrophilic polyrotaxane with respect to the coating film forming component, where the hydrophilic polyrotaxane has a cyclic molecule, a linear molecule included in the cyclic molecule in a skewered manner and blocking groups arranged on opposite ends of the linear molecule to prevent elimination of the cyclic molecule from the linear molecule and at least one of the linear molecule and the cyclic molecule has a hydrophilic modifying group. | 06-24-2010 |
| 20100147450 | METHOD OF FORMING BILAYER MEMBRANE BY CONTACT BETWEEN AMPHIPATHIC MONOLAYERS AND APPARATUS THEREFOR - The present invention provides a simple and an accurate method of forming a bilayer membrane by the contact of amphipathic monolayers and an apparatus therefor. The method is characterized in that the organic solvent ( | 06-17-2010 |
| 20100144849 | METHOD FOR INHIBITING SIGNALING MEDIATED BY ErbB2, SIGNALING INHIBITOR TO BE USED THEREFOR AND USE THEREOF - An object of the present invention is to provide a method for inhibiting activation of signaling pathway mediated by ErbB2 in a human cell and a signaling inhibitor to be used therefor. The above-described activation of signaling pathway can be inhibited by a polypeptide comprising at least one of PTB domain or ERK2 binding domain of human FRS2β. The above-described polypeptide may be introduced directly into a cell, or nucleic acid which encodes for the above-described polypeptide may be introduced into a cell to allow expression of the polypeptide in the cell. Such polypeptide and nucleic acid can be used, for example, as a signaling inhibitor. In addition, since ErbB2 is involved in development of cancer, the above-described signaling inhibitor is also useful, for example, as an anticancer drug. | 06-10-2010 |
| 20100135993 | METHOD OF TREATING MALIGNANT MESOTHELIOMA - The present invention relates to a therapeutic agent for malignant mesothelioma comprising a substance which inhibits binding of CD26 to extracellular matrix such as an siRNA targeting CD26 cDNA or an anti-CD26 antibody. The present invention also relates to a method of treating malignant mesothelioma, which comprises administering the substance to a patient in need thereof. | 06-03-2010 |
| 20100129677 | Material for Curable Aqueous Overcoating Material and Coating Material Using Same - There is provided a curable aqueous overcoating composition containing 1 to 90 mass % of hydrophilic polyrotaxane with respect to the coating film forming component, where the hydrophilic polyrotaxane has a cyclic molecule, a linear molecule included in the cyclic molecule in a skewered manner and blocking groups arranged on opposite ends of the linear molecule to prevent elimination of the cyclic molecule from the linear molecule and at least one of the linear molecule and the cyclic molecule has a hydrophilic modifying group. | 05-27-2010 |
| 20100128920 | SPATIAL INFORMATION DATABASE GENERATING DEVICE AND SPATIAL INFORMATION DATABASE GENERATING PROGRAM - An orthographic projection creating unit creates an orthographic projection image from an optical image of an ground surface acquired by an optical camera, and a DSM generating unit generates a DSM from the orthographic projection image. A laser point group data generating unit generates three-dimensional point group data based on a laser measurement result of the ground surface by a laser measuring device. An object generating unit groups altitude data of the DSM and altitude data of the three-dimensional point group data for each of objects such as buildings. A synthesizing unit extracts the same objects from the grouped altitude data of the DSM and three-dimensional point group data, associates the objects with each other based on respective coordinate information thereof, and replaces altitude information of the optical image by high-accuracy altitude information of the three-dimensional point group data for each of the objects. | 05-27-2010 |
| 20100127595 | ELECTRET AND ELECTROSTATIC INDUCTION CONVERSION DEVICE COMPRISING THE SAME - To provide an electret whose surface potential is improved and an electrostatic induction conversion device comprising the same, an electret is formed by spin-coating a fluorine-containing polymer composition for coating which contains a fluorine-containing polymer having a ring structure in its main chain, a silane coupling agent, an aprotic fluorine-containing solvent, and a fluorine-containing alcohol as a protic fluorine-containing solvent on a copper substrate and baking it. | 05-27-2010 |
| 20100123370 | PIEZOELECTRIC/ELECTROSTRICTIVE CERAMICS COMPOSITION, PIEZOELECTRIC/ELECTROSTRICTIVE CERAMICS SINTERED BODY, PIEZOELECTRIC/ELECTROSTRICTIVE ELEMENT, MANUFACTURING METHOD OF PIEZOELECTRIC/ELECTROSTRICTIVE CERAMICS COMPOSITION, AND MANUFACTURING METHOD OF PIEZOELECTRIC/ELECTROSTRICTIVE ELEMENT - [Object] To provide piezoelectric/electrostrictive ceramics and a piezoelectric/electrostrictive element with a large electric field-induced strain without performing an aging treatment. | 05-20-2010 |
| 20100122360 | Organ regeneration method utilizing blastocyst complementation - An object of the present invention is to produce a mammalian organ having a complicated cellular composition composed of multiple kinds of cells, such as kidney, pancreas, thymus and hair, in the living body of a non-human animal. The inventors of the present invention applied the chimeric animal assay described above, to a novel solid organ production method. More specifically, the inventors has shown that a model mouse which is deficient of kidney, pancreas, thymus or hair due to the dysfunction of the metanephric mesenchyme that is differentiated into most of an adult kidney, is rescued by blastocyst complementation by the chimeric animal assay, and whereby a kidney, a pancreas, thymus or hair can be newly produced. | 05-13-2010 |
| 20100120064 | ANTIBODY SPECIFIC TO INTACT HUMAN AUTOTAXIN, METHOD OF SCREENING THE SAME AND METHOD AND REAGENT FOR EXAMINING MALIGNANT LYMPHOMA BY ASSAYING AUTOTAXIN - A screening method is provided for antibody specifically recognizing naturally-occurring form of human autotaxin in a state in which it is present in the body without being denatured, comprising the steps of: binding a binding factor capable of capturing a candidate antibody of the antibody to a solid phase; binding the candidate antibody of the antibody to the binding factor; allowing naturally-occurring form of human autotaxin to react on a system in which the candidate antibody has reacted; and selecting an antibody that specifically recognizes the naturally-occurring form of human autotaxin by using as an indicator thereof the binding strength of the naturally-occurring form of human autotaxin to the antibody. Moreover, a detecting method for malignant lymphoma is provided comprising: measuring the concentration of autotaxin in a human specimen, and judging to be a malignant lymphoma in the case that value exhibits a significantly higher value than normal values comprised of measured values from normal healthy subjects. | 05-13-2010 |
| 20100114520 | TEST APPARATUS, TEST METHOD, PROGRAM, AND RECORDING MEDIUM REDUCING THE INFLUENCE OF VARIATIONS - Provided is a test apparatus that tests a device under test, including a vector expanding section that sequentially generates a plurality of test vectors; a predicting section that calculates a predicted value for each test vector by simulating an operation of the device under test, the predicted value indicating a prescribed characteristic value of the device under test to be measured while the device under test is supplied with a test signal corresponding to the test vector; a measuring section that obtains a measured value for each test vector by measuring the prescribed characteristic value of the device under test each time the device under test is supplied with a test vector; and a judging section that judges whether the device under test is defective based on a ratio between the predicted value and the measured value corresponding to each test vector. | 05-06-2010 |
| 20100111870 | EVALUATION METHOD AND SCREENING METHOD FOR SUBSTANCE HAVING ACTION OF ACTIVATING/SUPPRESSING INNATE IMMUNITY, AGENT AND FOOD PRODUCT FOR ACTIVATING/SUPPRESSING INNATE IMMUNE MECHANISM AND METHOD FOR PRODUCING THE SAME - It is intended to provide an evaluation method and a screening method capable of eliminating a substance that disturbs in vivo kinetics in an individual and capable of simply and easily searching a substance having an action of activating/suppressing an innate immune mechanism without being affected by LPS derived from bacteria, which can be contaminated during the search, as well as a drug and a food for activating/suppressing the innate immune mechanism, and methods of producing the same. The present invention provides a method of evaluating or screening the substance having the action of activating/suppressing the innate immune mechanism using a muscular contraction of an organism having the innate immune mechanism as an indicator, and methods of producing the drug and the food for activating/suppressing the innate immune mechanism. Also, an innate immunity activator and the food having the action of activating the innate immune mechanism containing the substance having the action of contracting the muscle of the organism having the innate immune mechanism, and an innate immunity suppressor and the food having the action of suppressing the innate immunity containing the substance having the action of suppressing the contraction of the muscle of the organism having the innate immune mechanism are provided. | 05-06-2010 |
| 20100111851 | DIAGNOSIS AND TREATMENT OF CANCER BY USING ANTI-PRG-3 ANTIBODY - The present invention discloses an antibody capable of binding to the PRG-3 protein and inhibiting the growth of cells expressing the PRG-3 protein. The growth inhibitory activity is cytotoxic activity, such as antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity. The present invention also discloses a pharmaceutical composition, cell growth inhibitor, and an anticancer agent comprising the antibody of the present invention as an active ingredient. Examples of the type of cancer include hepatocellular carcinoma, lung cancer, colon cancer, and glioblastoma. In addition, the present invention discloses a method for diagnosing cancer by detecting expression of the PRG-3 protein or the gene encoding the PRG-3 protein, as well as a diagnostic agent and kit for use in the method. | 05-06-2010 |
| 20100105901 | SYNTHESIS METHOD OF POLYMER COMPLEX CRYSTAL - Disclosed is a synthesis method for synthesizing in a short time and selectively a microcrystal of a polymer complex having three three-dimensionally and regularly arranged channels. | 04-29-2010 |
| 20100105893 | METHOD FOR PRODUCING epsilon-CAPROLACTAM AND METHOD FOR PRODUCING PENTASIL TYPE ZEOLITE - The present invention provides a method which can produce ε-caprolactam with a good selectivity by reacting cyclohexanone oxime with a good conversion in a vapor phase Beckmann rearrangement reaction. Disclosed is a method for producing ε-caprolactam, which comprises performing a vapor phase Beckmann rearrangement reaction of cyclohexanone oxime in the presence of a pentasil type zeolite, wherein the pentasil type zeolite is a zeolite obtained by subjecting a mixture containing a silicon compound, water, and a compound represented by formula (I): | 04-29-2010 |
| 20100098720 | Substance preventing adverse actions of therapeutic agents for dyslipidemia - A substance preventing adverse actions of conventional fibrate-series drugs as therapeutic agents for the metabolic syndrome and dyslipidemia to enhance the therapeutic effects thereof comprises an extract from | 04-22-2010 |
| 20100092457 | Diagnosis and Treatment of Cancer Using Anti-Desmoglein-3 Antibodies - Methods that involve detection of a DSG3 protein for diagnosing cancer are disclosed. In lung cancer, the expression of DSG3 was found to be enhanced at very high frequency at the gene level and protein level. Methods of the present invention can be carried out using an antibody that recognizes a DSG3 protein. Pharmaceutical compositions, cell growth inhibitors, and anticancer agents containing a DSG3-binding antibody as an active ingredient are also disclosed. Methods of inducing cell damage in DSG3-expressing cells and methods of suppressing proliferation of DSG3-expressing cells by contacting the DSG3-expressing cells with DSG3-binding antibodies are also disclosed. | 04-15-2010 |
| 20100089560 | HEAT EXCHANGER - A heat exchanger assembled from multiple heat exchanging tubes. Each of the multiple heat exchanging tubes is formed as a flattened tube of 0.5 mm in thickness by press work or bending work of a stainless steel plate member having a thickness of 0.1 mm. Each of the multiple heat exchanging tubes is structured to have multiple lines of sequential wave crests and multiple lines of sequential wave troughs formed on each of flattened faces of the heat exchanging tube. The multiple lines of the sequential wave crests and the multiple lines of the sequential wave troughs are arranged to have a preset angle γ relative to a main stream of an air flow. The lines of the sequential wave crests and the lines of the sequential wave troughs are symmetrically folded back about folding lines arranged at a preset interval W along the main stream of the air flow. | 04-15-2010 |
| 20100080356 | CHARGED PARTICLE BEAM DECELERATING DEVICE AND METHOD, AND X-RAY GENERATING APPARATUS USING THE SAME - A charged particle beam decelerating device includes a high-frequency cavity | 04-01-2010 |
| 20100076180 | Method of fixing rail molecule and nano transport device - An object is to move a rail molecule by means of a biomolecular motor deposited on a base and inactivate the biomolecular motor through irradiation with light having a predetermined wavelength, to thereby readily and reliably fix the rail molecule at a predetermined position, while orienting the rail molecule in a predetermined direction without employment of any reagent. A method for fixing a rail molecule which has polarity and on which a biomolecular motor moves in a direction corresponding to the polarity includes depositing a biomolecular motor on a base; moving a rail molecule by means of the biomolecular motor; and inactivating the biomolecular motor by irradiating the biomolecular motor with light having a predetermined wavelength when the rail molecule reaches a predetermined position, to thereby fix the rail molecule so that it is oriented in a predetermined direction. | 03-25-2010 |
| 20100071886 | HEAT EXCHANGER | 03-25-2010 |
| 20100069455 | BONE MODEL, BONE FILLER AND PROCESS FOR PRODUCING BONE FILLER - A method for producing a bone filler basically comprising: a bone model producing step (step 1) for producing a bone model; a figure forming material filling step (step 2) for filling a figure forming material into a bone defect site of the bone model obtained in the bone model producing step; and a bone filler producing step (step 3) for producing a bone filler which is to be filled in a bone defect site based on the figure forming material filled in the bone defect site of the bone model in the figure forming material filling step. | 03-18-2010 |
| 20100068733 | pH-Sensitive Fluorescent Probe - A compound represented by the following general formula (I): | 03-18-2010 |
| 20100068694 | METHOD, REAGENT AND KIT FOR MALARIA TESTING - The present invention provides a method for malaria testing which enables testing for the presence of malaria infection and the extent of the infection in a convenient manner; and a reagent or kit which can be used in the method. The method for malaria testing according to the present invention includes the step of detecting a liver-type fatty acid binding protein present in urine collected from a subject animal. The extent of infection is determined to be higher when a larger amount of the liver-type fatty acid binding protein is present in a test sample. | 03-18-2010 |
| 20100062978 | METHOD FOR INHIBITING SIGNAL TRANSDUCTION, SIGNAL TRANSDUCTION INHIBITOR TO BE USED THEREIN AND USE THEREOF - An object of the present invention is to provide a method for inhibiting activation of signaling pathway mediated by erbB1 or erbB2 in human cell and a signaling inhibitor to be used therefor. The above-described activation of signaling pathway can be inhibited by a polypeptide comprising at least one of PTB domain or ERK2 binding domain of human FRS2β. The above-described polypeptide may be introduced directly into cell, or nucleic acid which encodes for the above-described polypeptide may be introduced into cell to allow expression of the polypeptide in the cell. Such polypeptide and nucleic acid can be used, for example, as a signaling inhibitor. In addition, since erbB1 and erbB2 are involved in development of cancer, the above-described signaling inhibitor is also useful, for example, as an anticancer drug. | 03-11-2010 |
| 20100062449 | Method Of Measuring PTX3 With High Sensitivity - To provide a method of determining vasculopathy, which is a risk factor of myocardial infarction, angiopathic dementia, etc., at an early stage thereof (i.e., mild vasculopathy). The present invention provides a method of determining the severity of mild vasculopathy, including determining PTX3 level in an assay sample by use of an anti-PTX3 monoclonal antibody. | 03-11-2010 |
| 20100060981 | Circular Dichroic Thermal Lens Microscope - An objective of the present invention is to provide a circular dichroism thermal lens microscope apparatus capable of identifying and quantifying optically active samples in ultra-trace amounts, and which has a higher sensitivity than conventional apparatuses. | 03-11-2010 |
| 20100058131 | TEST APPARATUS, TEST VECTOR GENERATE UNIT, TEST METHOD, PROGRAM, AND RECORDING MEDIUM - Provided is a test apparatus that tests a device under test, including a vector expanding section that sequentially generates a plurality of test vectors; a vector selecting section that selects test vectors that cause a prescribed characteristic of the device under test, which is to be measured when test signals that are each based on one of the test vectors are supplied to the device under test, to fulfill a preset condition; and a judging section that judges pass/fail of the device under test based on measured values of the prescribed characteristic of the device under test supplied with the test signal based on the test vectors selected by the vector selecting section. | 03-04-2010 |
| 20100047921 | METHOD FOR ISOLATION OF BIOPOLYMER BY USING RE-CIRCULATING CHROMATOGRAPHY - It is an object of the present invention to provide a method for isolating biopolymers, which is capable of simultaneously isolating many types of biopolymers from a single biological sample under the same conditions. The present invention provides a method for isolating biopolymers, which comprises repeating at least twice a process consisting of: (1) a step of preparing at least two vessels each containing a carrier retaining a substance having an affinity for a target biopolymer; then simultaneously introducing a single sample solution containing the target biopolymer into at least the two vessels, and then allowing said sample solution to come into contact with said carrier, so that the target biopolymer can be adsorbed on said carrier; (2) a step of discharging said sample solution from said vessels; and (3) a step of stirring the discharged sample solution. | 02-25-2010 |
| 20100045137 | ACTUATOR AND METHOD FOR MANUFACTURING THE SAME - An actuator that can be driven at a reduced voltage and manufactured with ease, and a method for manufacturing the same are provided. The actuator includes second supporting portions 31 and 32 secured to a supporting substrate 4 through a spacer, fixed portions 33 and 34 secured to the supporting substrate 4 with no intervention of the spacer, fixed comb electrodes 331 and 341 integrally formed the fixed portions 33 and 34 and meshing with movable comb electrodes 211 and 212 in a spaced-apart relationship, and bridge portions 35 and 36 for connecting the fixed portions 33 and 34 to the second supporting portions 31 and 32. The fixed portions 33 and 34 are affixed to the supporting substrate 4 in a condition that they are deflected toward the supporting substrate 4 with respect to the second supporting portions 31 and 32 while bending the bridge portions 35 and 36, thereby initially deflecting the fixed comb electrodes 331 and 341 so as to be out of alignment with the movable comb electrodes 211 and 212 in a thickness direction of the supporting substrate 4. | 02-25-2010 |
| 20100041167 | DRUG FOR DIAGNOSING LARGE INTESTINAL CANCER AND/OR POLYP, OBSERVING POSTOPERATIVE COURSE AND MONITORING RECURRENCE - The present invention is directed to a method for diagnosing large intestinal cancer and/or polyp and a method for observing postoperative course or monitoring recurrence thereof, wherein each method includes detecting cystatin SN protein by use of an anti-cystatin SN antibody. The present invention is able to provide a kit for assaying cystatin SN, which can be used, in a simple manner, in a diagnosis performed prior to conventional barium enema examination and endoscopic examination which impose burdens on patients; as an indicator of metastasis and recurrence; and in the evaluation of therapeutic effects. The present invention provides a method for diagnosing or monitoring large intestinal cancer and/or polyp which can be performed in a simple manner, and thus can allow to design a new regimen rapidly. | 02-18-2010 |
| 20100035837 | THERAPEUTIC OR PROPHYLACTIC AGENT FOR VASOCONSTRICTION - An object of the present invention is to provide an agent for treating or preventing vasospasm. An object of the present invention is to provide an agent for treating or preventing cerebral vasospasm as well as arterial vasospasm. Further, an object of the present invention is to provide an agent for treating or preventing cerebral ischemia and cerebral infarction. | 02-11-2010 |
| 20100033796 | Optical module, optical control method by optical module, optical switch, and optical switching method - An optical module includes a mirror which reflects input light and which outputs output light; and a mirror control section which is opposite to the mirror and which controls, at the time of the input light being reflected from a reflecting surface of the mirror, the reflecting surface by distorting the reflecting surface according to voltage applied to the mirror so as to output the output light an optical coupling characteristic of which changes. By using this optical module, the optical coupling characteristic of the output light changes. | 02-11-2010 |
| 20100030679 | Transreceiver, commodity and service trading system, and transmitter and receiver used therein - In a commodity and service trading system, a client computer | 02-04-2010 |
| 20100019357 | SEMICONDUCTOR DEVICE AND METHOD FOR MANUFACTURING THE SAME - A gate insulating film having a high dielectric constant, a semiconductor device provided with the gate insulating film, and a method for manufacturing such film and device are provided. The semiconductor device is provided with a group 14 (IVB) semiconductor board and a first oxide layer. The first oxide layer is composed of MO | 01-28-2010 |
